[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1117
1. Nasser F, Affonso BB, de Jesus-Silva SG, Coelho Dde O, Zlotnik E, Messina Mde L, Baracat EC: [Uterine fibroid embolization in women with giant fibroids]. Rev Bras Ginecol Obstet; 2010 Nov;32(11):530-5
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Embolização de mioma uterino em mulheres portadoras de miomas volumosos.

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21271163.001).
  • [ISSN] 1806-9339
  • [Journal-full-title] Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
  • [ISO-abbreviation] Rev Bras Ginecol Obstet
  • [Language] por
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


2. Fatima S, Ahmed Z, Azam M: Benign metastasizing leiomyoma. Indian J Pathol Microbiol; 2010 Oct-Dec;53(4):802-4
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign metastasizing leiomyoma.
  • Benign metastasizing leiomyoma (BML) is a rare condition, affecting predominantly reproductive-age females with uterine leiomyomata and is most often associated with multiple benign-appearing smooth muscle tumors in lungs.
  • We report herein a case of a 38-year-old woman who presented with multiple uterine fibroids for which hysterectomy was carried out on her.
  • Histopathology of one of the pleura-based nodules revealed a neoplasm composed of interlacing fascicles of spindle cells with uniform nuclei.
  • The tumor cells were positive for alpha-smooth muscle actin and negative for CD34 immunohistochemical stain.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21045423.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / ACTA2 protein, human; 0 / Actins; 0 / Antigens, CD34
  •  go-up   go-down


3. Bodner-Adler B, Bartl M, Wagner G: Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma? Anticancer Res; 2009 Feb;29(2):495-6
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
  • BACKGROUND: Intravenous leiomyomatosis (IVL) is defined as an intraluminal growth of benign smooth muscle cells in either venous or lymphatic vessels outside the confines or even in the absence of leiomyomas.
  • Benign metastasizing uterine leiomyoma is defined as a histologically benign uterine smooth muscle tumor that acts in a somewhat malignant fashion and produces benign metastases.
  • We report a case of a patient suffering from IVL of the uterus and pulmonary leiomyomatosis.
  • The patient was put on a regimen of gonadotropin-releasing hormone for a total of 6 months and a lung scan after 6 months revealed stable disease.
  • CONCLUSION: Though intravenous leiomyomatosis imitates a malignant neoplasm concerning the pattern of growth and extension, and benign metastasizing leiomyoma produces benign metastases, they must be differentiated histologically from malignant tumors to prevent overtreatment.


Advertisement
4. Cîmpean AM, Raica M, Nariţa D: Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast. Rom J Morphol Embryol; 2005;46(2):123-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
  • PURPOSE: Our aim was to investigate the distribution of CD34 and smooth muscle cell actin positive myofibroblasts in the stroma of the normal mammary gland, benign and malignant tumors.
  • RESULTS: We have found normal breast tissue, sclerosing adenosis, fibroadenomas, fibrocystic diseases, phyllodes tumor, DCIS, ductal invasive, lobular, squamous, medullary, mucinous, and papillary carcinomas.
  • All the normal breast tissues and most of benign lesions were positive for CD34 and negative for SMA.
  • The exceptions were represented by a case of fibroadenoma and the phyllodes tumor, with CD34 positivity and a focal acquisition of SMA; fibrocystic disease with associated apocrine metaplasia adjacent to a squamous carcinoma with loss of CD34 expression and focal acquisition of SMA.
  • CONCLUSIONS: Although there were some exceptions especially when one of the two markers was interpreted separately and in some cases associated with sclerotic stroma, we conclude that the combined expression of CD34 and a-SMA is of potential diagnostic value in the distinction between benign and malignant tumors in some difficult cases.
  • [MeSH-major] Actins / analysis. Antigens, CD34 / analysis. Breast Neoplasms / pathology. Muscle, Smooth / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antigens, CD / analysis. Biopsy. Carcinoma, Ductal / pathology. Female. Fibrocystic Breast Disease / pathology. Humans. Middle Aged. Neoplasm Invasiveness. Smad Proteins / analysis

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16286998.001).
  • [ISSN] 1220-0522
  • [Journal-full-title] Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
  • [ISO-abbreviation] Rom J Morphol Embryol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Romania
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD; 0 / Antigens, CD34; 0 / Smad Proteins
  •  go-up   go-down


5. Hrgović Z, Kulas T, Habek D, Izetbegović S, Hrgović I: [New options in the diagnosis and management of uterine myoma]. Med Arh; 2008;62(4):234-9
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [New options in the diagnosis and management of uterine myoma].
  • [Transliterated title] Nove mogućnosti u dijagnostici i lijecenju mioma maternice.
  • Myoma accounts for nearly 95% of all benign tumors of female genital organs and is the most common neoplasm of female genital tract.
  • Along with thorough history and gynecologic examination, ultrasound study is of utmost importance in the diagnosis of myoma; magnetic resonance (MR) study may also be required in rare cases.
  • A number of therapeutic options are available for the management of myoma, ranging from medicamentous therapy through operative procedures (e.g., total or supracervical hysterectomy or myoma enucleation) and novel non-operative procedures (e.g., embolization of uterine artery (EUA) and magnetic resonance guided focused ultrasound (MRgFUS).
  • Discomforts caused by a myoma are an absolute indication for treatment.
  • Therapeutic option to be chosen is determined by the number, size and location of myomas, and the patient's preferences.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19145810.001).
  • [Journal-full-title] Medicinski arhiv
  • [ISO-abbreviation] Med Arh
  • [Language] bos
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Bosnia and Herzegovina
  • [Number-of-references] 61
  •  go-up   go-down


6. Vázquez Camacho EE, Cabrera Carranco E, Sánchez Herrera RG: [Pedunculated twisted myoma and pregnancy. Case report]. Ginecol Obstet Mex; 2009 Sep;77(9):441-4
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pedunculated twisted myoma and pregnancy. Case report].
  • [Transliterated title] Mioma pediculado torcido en una mujer embarazada. Reporte de caso.
  • The detection of a pelvic mass during pregnancy is uncommon.
  • We report a case of a woman at the 15 week of gestation with torsi6n of a pedunculated mioma mimicking in the ultrasonografic image an ovarian tumor.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19899435.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


7. Costa Benavente L, Silva Barroso F, Avila Flores E: [Giant uterine myoma]. Ginecol Obstet Mex; 2005 Oct;73(10):563-5
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant uterine myoma].
  • [Transliterated title] Mioma uterino gigante.
  • We report the case of a 45-year old woman with a large abdominal mass and three-day history of constipation and respiratory difficulty.
  • Total abdominal hysterectomy and bilateral salpingo-oophorectomy was performed, and a giant uterine myoma, which weighted 12.4 kg (27.3 lb), was found.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16583838.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  • [Number-of-references] 7
  •  go-up   go-down


8. Bugalho A, Oliveira A, Semedo J, Lourenço I, Carreiro L: Argon-plasma treatment in benign metastasizing leiomyoma of the lung: a case report. Rev Port Pneumol; 2010 Nov-Dec;16(6):921-3; discussion 925
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Argon-plasma treatment in benign metastasizing leiomyoma of the lung: a case report.
  • Benign metastasizing leiomyomas of the lung are rare smooth muscle cells tumours.
  • We report the case of a 48 year-old female who was evaluated due to persistent cough, progressive dyspnoea and constitutional symptoms.
  • Bronchial biopsy histological features were consistent with benign metastasizing leiomyoma.
  • There was no disease relapse in the last four years.
  • [MeSH-minor] Female. Humans. Middle Aged. Neoplasm Metastasis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21067700.001).
  • [ISSN] 2172-6825
  • [Journal-full-title] Revista portuguesa de pneumologia
  • [ISO-abbreviation] Rev Port Pneumol
  • [Language] eng; por
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Portugal
  •  go-up   go-down


9. Pérez-Cejudo JA, Piqué E, Arduan I, Palacios S, Sánchez C, Rodríguez M, Morales R: [Umbilical cutaneous endometriosis associated with a large uterine myoma]. Actas Dermosifiliogr; 2005 Jan-Feb;96(1):43-5
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Umbilical cutaneous endometriosis associated with a large uterine myoma].
  • [Transliterated title] Endometriosis cutánea umbilical asociada a mioma uterino gigante.
  • The Dermatology Department was consulted because of an asymptomatic umbilical tumor which had been developing for 5 years.
  • [MeSH-major] Endometriosis / complications. Leiomyoma / complications. Skin Diseases / complications. Umbilicus. Uterine Neoplasms / complications


10. Squillaci S, Cecchetti D, Tallarigo F, Pontieri F, Filardo AV: [Myopericytoma-type perivascular myoma located in the soft tissue of the foot: a case report and review of the literature]. Pathologica; 2005 Dec;97(6):378-82
MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Myopericytoma-type perivascular myoma located in the soft tissue of the foot: a case report and review of the literature].
  • [Transliterated title] Mioma perivascolare di tipo miopericitoma dei tessuti molli del piede: descrizione di un caso e revisione della letteratura.
  • We describe a rare case of myopericytoma-type perivascular myoma (MTPM) which arose in acral location and the literature on this field is briefly reviewed.
  • Immunohistochemically, the neoplastic cells were positive for vimentin, smooth muscle actin, desmin and calponin, negative for S-100 protein, CD34, CD31 and cytokeratins (AE1/AE3, Cam 5.2).
  • [MeSH-major] Foot Diseases / pathology. Myoma / pathology. Soft Tissue Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16619980.001).
  • [ISSN] 0031-2983
  • [Journal-full-title] Pathologica
  • [ISO-abbreviation] Pathologica
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 16
  •  go-up   go-down


11. Jeda A, Karoń J, Rak M: [The nodule of the small intestine--a rare case of benign metastasizing leiomyoma]. Ginekol Pol; 2009 Sep;80(9):716-9
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The nodule of the small intestine--a rare case of benign metastasizing leiomyoma].
  • [Transliterated title] Guzek jelita cienkiego--rzadki przypadek mieśniaka przerzutowego (benign metastasizing leiomyoma).
  • The diagnosis of benign metastasizing leiomyoma BML is a casuic case.
  • The term is used to describe a entity of neoplasms characterized by a proliferation of smooth muscle cells with low mitotic index, usually located outside female genital organs.
  • In the world literature there are reports of benign metastasizing leiomyomas in the lungs, skull base and spine, the lymph nodes of the small pelvis and the heart.
  • In the following study the authors analyzed a case of a 72-year-old woman in which, during hysterectomy due to uterine leiomyomas, a nodule of the small intestine was found, confirmed histologically as leiomyoma.
  • [MeSH-minor] Aged. Female. Humans. Hysterectomy. Intestine, Small. Neoplasm Metastasis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19886249.001).
  • [ISSN] 0017-0011
  • [Journal-full-title] Ginekologia polska
  • [ISO-abbreviation] Ginekol. Pol.
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


12. Awonuga AO, Rotas M, Imudia AN, Choi C, Khulpateea N: Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo-oophorectomy. Arch Gynecol Obstet; 2008 Oct;278(4):373-6
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo-oophorectomy.
  • BACKGROUND: Benign uterine leiomyomas are sometimes found in association with benign smooth muscle tumors outside the confines of the uterus and are given the name benign metastasizing leiomyomas (BML).
  • PATIENTS: Our patients, presented with multiple abdominal masses 6 years after their initial surgery for benign leiomyoma.
  • At exploratory laparotomy multiple benign leiomyomas were resected, and in one case a 2.2 cm leiomyoma was also resected from the left lower lobe of the lung.
  • RESULTS: Pathology revealed benign leiomyomas with no cytological atypia and a mitotic count of <5 per 10 high power fields (hpf).
  • CONCLUSION: Benign metastasizing leiomyoma rarely follow TAH/BSO in patients with uterine myoma and estrogen replacement therapy may play a role in such occurrence.
  • [MeSH-major] Leiomyomatosis / pathology. Lung Neoplasms / secondary. Neoplasm Recurrence, Local / pathology. Uterine Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18259767.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


13. Miettinen M, Makhlouf HR, Sobin LH, Lasota J: Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. Am J Surg Pathol; 2009 Nov;33(11):1624-32
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.
  • A great majority of gastric mesenchymal tumors are gastrointestinal stromal tumor (GIST).
  • In this report, we describe 12 cases of a distinctive gastric tumor, named here as plexiform fibromyxoma.
  • The tumor cells varied from oval to spindled and had limited atypia and mitotic activity < 5/50 high-power fields.
  • Immunohistochemically, the tumor cells were positive for alpha smooth muscle actin, and variably for CD10, and were consistently negative for KIT, DOG1, CD34, desmin, and S100 protein.
  • Additional 3 patients survived 14 to 25 years with unknown tumor status.
  • Plexiform fibromyxoma is a distinctive benign gastric antral neoplasm that should be separated from GIST, nerve sheath tumors, and other fibromyxoid neoplasms.
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Child. Diagnosis, Differential. Disease-Free Survival. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Invasiveness. Young Adult

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19675452.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


14. Nucci MR, Drapkin R, Dal Cin P, Fletcher CD, Fletcher JA: Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications. Am J Surg Pathol; 2007 May;31(5):737-43
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications.
  • "Benign metastasizing leiomyoma" is the terminology used to describe a controversial entity characterized by a proliferation of bland-appearing smooth muscle in lung or abdominopelvic lymph nodes.
  • In this report, we describe 5 cases of pulmonary-based smooth muscle tumors that are clinically and histologically consistent with this entity, and in which we identified consistent chromosomal aberrations (19q and 22q terminal deletion in all cases).
  • This cytogenetic profile is found in approximately 3% of uterine leiomyoma, but has not been described in other types of benign or malignant neoplasia.
  • These findings suggest that the nodular pulmonary smooth muscle proliferations termed "benign metastasizing leiomyoma," are a genetically distinct entity, which likely originate from a biologically distinctive subset of uterine leiomyoma.
  • [MeSH-minor] Actins / analysis. Biomarkers, Tumor. Chromosome Deletion. Chromosomes, Human, Pair 19. Chromosomes, Human, Pair 22. Desmin / analysis. Female. Humans. Karyotyping. Middle Aged. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17460458.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor; 0 / Desmin
  •  go-up   go-down


15. Zhen B, Shen Y, Zhang YM, Zhu CH, Liu ZL: [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues]. Zhonghua Nan Ke Xue; 2006 May;12(5):416-20
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
  • OBJECTIVE: To examine the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia (BPH) and prostatic cancer (PCa) tissues and to analyse the relationship between their expression and BPH and PCa, especially the relationship with the occurrence, development, prognosis and treatment of PCa.
  • The staining for c-kit in BPH tissues was located in the cytoplasm of smooth muscle cells, and in PCa tissues was located in epithelial cells.
  • CONCLUSION: The expression level of HSP27 and c-kit was highly correlated with the process of the development from BPH to PCa, and also correlated with tumor grades and stages.
  • [MeSH-major] Heat-Shock Proteins / biosynthesis. Neoplasm Proteins / biosynthesis. Prostatic Hyperplasia / metabolism. Prostatic Neoplasms / metabolism. Proto-Oncogene Proteins c-kit / biosynthesis

  • Genetic Alliance. consumer health - Benign Prostatic Hyperplasia.
  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16755871.001).
  • [ISSN] 1009-3591
  • [Journal-full-title] Zhonghua nan ke xue = National journal of andrology
  • [ISO-abbreviation] Zhonghua Nan Ke Xue
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / HSP27 Heat-Shock Proteins; 0 / HSPB1 protein, human; 0 / Heat-Shock Proteins; 0 / Neoplasm Proteins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


16. Mentzel T, Kutzner H: Dermatomyofibroma: clinicopathologic and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasm. Am J Dermatopathol; 2009 Feb;31(1):44-9
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dermatomyofibroma: clinicopathologic and immunohistochemical analysis of 56 cases and reappraisal of a rare and distinct cutaneous neoplasm.
  • Dermatomyofibroma represents a rare and distinct benign cutaneous mesenchymal neoplasm of fibroblastic/myofibroblastic differentiation.
  • Histologically, an ill-defined, plaque-like dermal neoplasm of varying cellularity was seen in all cases, composed of bland spindle-shaped tumor cells often oriented parallel to the overlying epidermis.
  • Immunohistochemically, tumor cells in 11 of 48 cases tested stained positively for alpha-smooth muscle actin, and a focal expression of this marker was noted in 20 cases.
  • Dermatomyofibroma represents a benign fibroblastic/myofibroblastic dermal neoplasm.
  • [MeSH-major] Histiocytoma, Benign Fibrous / metabolism. Histiocytoma, Benign Fibrous / pathology. Skin Neoplasms / metabolism. Skin Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19155724.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Jin MS, Ha HJ, Baek HJ, Lee JC, Koh JS: Adenomyomatous hamartoma of lung mimicking benign mucinous tumor in fine needle aspiration biopsy: a case report. Acta Cytol; 2008 May-Jun;52(3):357-60
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenomyomatous hamartoma of lung mimicking benign mucinous tumor in fine needle aspiration biopsy: a case report.
  • BACKGROUND: Typical cytologic features of pulmonary hamartoma (PH) are usually smears of hyaline cartilage, fibrous tissue, smooth muscle, adipocytic components and respiratory epithelium.
  • Cytologic features of adenomyomatous hamartoma, a special variant of PH, are not documented in the literature and are confused with epithelial neoplasm in the case of sparse stromal cellularity.
  • Fine needle aspiration biopsy (FNAB) revealed numerous mucinous epithelial cells presenting predominantly in cohesive cellular sheets that suggested benign mucinous epithelial lesion.
  • The patient underwent surgery for the tumor, and it was histologically proven to be an adenomyomatous hamartoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18540306.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Moon H, Park SJ, Lee HB, Kim SR, Choe YH, Chung MJ, Jin GY, Lee YC: Pulmonary benign metastasizing leiomyoma in a postmenopausal woman. Am J Med Sci; 2009 Jul;338(1):72-4
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary benign metastasizing leiomyoma in a postmenopausal woman.
  • Pulmonary benign metastasizing leiomyoma (BML) is a rare disease occurring predominantly in women of reproductive age and usually develops several years after the resection of a uterine leiomyoma.
  • A 52-year-old postmenopausal woman was admitted to our hospital because of a right-sided empyema.
  • A wedge biopsy revealed the pulmonary nodule consisting of branching glandular structures surrounded by abundant smooth muscle cells with no atypia.
  • We performed a gynecologic examination to identify the primary origin of the pulmonary smooth muscle tumors.
  • This is an interesting case of pulmonary BML identified simultaneously with uterine myoma in a postmenopausal woman.
  • [MeSH-minor] Female. Humans. Middle Aged. Neoplasm Metastasis. Postmenopause

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19506459.001).
  • [ISSN] 0002-9629
  • [Journal-full-title] The American journal of the medical sciences
  • [ISO-abbreviation] Am. J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Asciutto G, Mumme A, Marpe B, Hummel T, Asciutto KC, Geier B: Deep venous thrombosis in a patient with large uterine myomata. Case report. Minerva Ginecol; 2008 Oct;60(5):451-3
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep venous thrombosis in a patient with large uterine myomata. Case report.
  • Computed tomography revealed an inhomogenous uterine enlargement due to multiple myomata producing a thrombotic occlusion of the left iliac veins.
  • Uterine myomata rarely cause acute iliac vein thrombosis due to direct compression.


20. Gaeta M, Mazziotti S, Minutoli F, Genitori A, Toscano A, Rodolico C, Blandino A: MR imaging findings of focal myositis: a pseudotumour that may mimic muscle neoplasm. Skeletal Radiol; 2009 Jun;38(6):571-8
MedlinePlus Health Information. consumer health - Myositis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MR imaging findings of focal myositis: a pseudotumour that may mimic muscle neoplasm.
  • RESULTS: Seven of eight lesions were located in the lower extremities, one of eight in the arm; four of eight involved part of a muscle, two of eight diffusely involved a muscle and two of eight showed multifocal involvement of two or more muscles.
  • Dynamic enhancement pattern corresponded to the type usually seen in benign soft tissue lesions.
  • CONCLUSION: Focal myositis is an uncommon pseudotumour which should be considered in the differential diagnosis of muscular masses and myopathies.
  • [MeSH-major] Magnetic Resonance Imaging / methods. Muscle Neoplasms / pathology. Muscle, Skeletal / pathology. Myositis / pathology

  • Genetic Alliance. consumer health - Myositis.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 2005 Jan-Feb;29(1):108-11 [15665694.001]
  • [Cites] Acta Chir Scand. 1985;151(1):77-80 [3157288.001]
  • [Cites] J Oral Maxillofac Surg. 1987 Nov;45(11):953-5 [3478443.001]
  • [Cites] J Rheumatol. 1993 Aug;20(8):1414-6 [8230031.001]
  • [Cites] Histopathology. 1994 Feb;24(2):171-3 [8181812.001]
  • [Cites] Fed Proc. 1978 Nov;37(13):2759-64 [213318.001]
  • [Cites] J Bone Joint Surg Am. 1982 Dec;64(9):1371-3 [7142247.001]
  • [Cites] Radiology. 1999 Apr;211(1):241-7 [10189479.001]
  • [Cites] J Magn Reson Imaging. 1996 Mar-Apr;6(2):311-21 [9132096.001]
  • [Cites] J Hand Surg Am. 1988 Jan;13(1):140-2 [3351219.001]
  • [Cites] J Comput Assist Tomogr. 2007 May-Jun;31(3):368-74 [17538281.001]
  • [Cites] Radiology. 1997 Apr;203(1):237-44 [9122401.001]
  • [Cites] Br J Radiol. 1991 Jun;64(762):489-93 [2070176.001]
  • [Cites] Ann Rheum Dis. 1996 Nov;55(11):856 [8976647.001]
  • [Cites] Radiology. 1989 Jun;171(3):767-73 [2717749.001]
  • [Cites] Acta Neurol Scand. 2005 Sep;112(3):173-7 [16097959.001]
  • [Cites] J Rheumatol. 1995 Jan;22(1):183-5 [7699670.001]
  • [Cites] J Comput Assist Tomogr. 1992 Jan-Feb;16(1):120-5 [1729290.001]
  • [Cites] AJR Am J Roentgenol. 2004 Oct;183(4):995-9 [15385292.001]
  • [Cites] Australas Radiol. 2001 Aug;45(3):347-9 [11531762.001]
  • [Cites] Skeletal Radiol. 2004 Jul;33(7):426-8 [15133638.001]
  • [Cites] Neurology. 2000 Jan 11;54(1):65-71 [10636127.001]
  • [Cites] Rheumatology (Oxford). 2002 Nov;41(11):1318-22 [12422007.001]
  • [Cites] Radiology. 1998 Sep;208(3):821-8 [9722866.001]
  • [Cites] Radiology. 1994 Sep;192(3):835-43 [8058957.001]
  • [Cites] Cancer. 1977 Jul;40(1):301-6 [880559.001]
  • [Cites] Hum Pathol. 1997 Jan;28(1):111-3 [9013843.001]
  • [Cites] Skeletal Radiol. 2000 Aug;29(8):425-38 [11026710.001]
  • [Cites] AJR Am J Roentgenol. 1989 May;152(5):1073-85 [2705342.001]
  • [Cites] Eur Radiol. 2000;10(2):213-23 [10663750.001]
  • [Cites] Br J Rheumatol. 1993 Dec;32(12 ):1101-4 [8252323.001]
  • [Cites] Skeletal Radiol. 2004 Jan;33(1):1-8 [14605767.001]
  • [Cites] J Pediatr Surg. 1986 Apr;21(4):375-6 [3701556.001]
  • [Cites] Muscle Nerve. 2000 Oct;23(10):1569-75 [11003793.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1979 Oct;48(4):337-41 [291860.001]
  • [Cites] Hum Pathol. 1979 May;10(3):353-6 [468219.001]
  • [Cites] Curr Opin Rheumatol. 1997 Nov;9(6):520-6 [9375281.001]
  • [Cites] Skeletal Radiol. 1998 May;27(5):283-7 [9638840.001]
  • [Cites] Radiographics. 2000 Oct;20 Spec No:S295-315 [11046180.001]
  • [Cites] Postgrad Med J. 1993 Nov;69(817):876-8 [8290436.001]
  • [Cites] Annu Rev Immunol. 1984;2:283-318 [6100475.001]
  • [Cites] Radiology. 2004 Nov;233(2):493-502 [15459325.001]
  • [Cites] Radiology. 1997 Mar;202(3):739-44 [9051028.001]
  • [Cites] Radiology. 1992 Jan;182(1):217-9 [1727285.001]
  • [Cites] Neuromuscul Disord. 1995 Jul;5(4):317-21 [7580245.001]
  • [Cites] Skeletal Radiol. 2002 May;31(5):307-10 [11981609.001]
  • (PMID = 19255757.001).
  • [ISSN] 1432-2161
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


21. Palmara V, Triolo O, Benedetto V, Lo Re C, Sturlese E, Retto G, Santoro G: Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate. Gynecol Obstet Invest; 2010;69(2):131-5
Hazardous Substances Data Bank. LEUPROLIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate.
  • AIM: We studied morphologic modifications of the endometrium induced by leuprorelin acetate, a gonadotropin-releasing hormone agonist, in women with uterine myomata.
  • RESULTS: A near-normal endometrium was observed after 2 months of therapy, while treatment with 6 cycles of leuprorelin acetate induced a uniform morphologic regression of the uterine mucosa.


22. McCluggage WG, Boyde A: Uterine angioleiomyomas: a report of 3 cases of a distinctive benign leiomyoma variant. Int J Surg Pathol; 2007 Jul;15(3):262-5
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine angioleiomyomas: a report of 3 cases of a distinctive benign leiomyoma variant.
  • We report 3 cases of a distinctive uterine leiomyoma containing numerous thick-walled vascular channels, which we term angioleiomyoma.
  • They were composed of bland, spindle-shaped cells with numerous evenly distributed, arteriole-like vessels with thick muscular walls throughout.
  • The spindle cells were positive with smooth-muscle markers and negative with HMB45.
  • We believe angioleiomyoma should be recognized as a distinct entity and included in the World Health Organization classification of tumors of the female genital tract as a benign leiomyoma variant, similar to cellular and atypical leiomyoma.
  • Uterine angioleiomyoma has a close morphological resemblance to the similarly named skin tumor.
  • We review uterine smooth-muscle and other mesenchymal neoplasms in which prominent vascular channels are a feature.
  • [MeSH-minor] Actins / genetics. Actins / metabolism. Adult. Antigens, Neoplasm. Calmodulin-Binding Proteins / genetics. Calmodulin-Binding Proteins / metabolism. Desmin / genetics. Desmin / metabolism. Female. Gene Expression Regulation, Neoplastic. Humans. Melanoma-Specific Antigens. Middle Aged. Neoplasm Proteins / genetics. Neoplasm Proteins / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17652533.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, Neoplasm; 0 / Calmodulin-Binding Proteins; 0 / Desmin; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins
  •  go-up   go-down


23. McLucas B, Chespak L, Kaminsky D: Myoma necrosis following Gelfoam embolization of uterine myomata. Minim Invasive Ther Allied Technol; 2008;17(3):200-4
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myoma necrosis following Gelfoam embolization of uterine myomata.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18666018.001).
  • [ISSN] 1365-2931
  • [Journal-full-title] Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
  • [ISO-abbreviation] Minim Invasive Ther Allied Technol
  • [Language] eng
  • [Publication-type] Comparative Study; Controlled Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Hemostatics
  •  go-up   go-down


24. Nezhat C, Kho K: Iatrogenic myomas: new class of myomas? J Minim Invasive Gynecol; 2010 Sep-Oct;17(5):544-50
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Iatrogenic myomas: new class of myomas?
  • Parasitic myomas, defined as extrauterine seeding of leiomyoma, have been reported since the early 1900s.
  • These myomas were thought to be spontaneously occuring, separate from the uterus but still hormone-dependent and can cause symptoms.
  • What seemed to be a rare disorder developing from the natural history of pedunculated myomas has become increasingly reported over the last decade.
  • Because it is still a rare disorder, the literature is limited to case reports.
  • [MeSH-major] Gynecologic Surgical Procedures / adverse effects. Leiomyoma / surgery. Neoplasm Seeding. Uterine Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Iatrogenic Disease. Middle Aged

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 AAGL. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20580324.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


25. Ip PP, Cheung AN, Clement PB: Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol; 2009 Jul;33(7):992-1005
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
  • BACKGROUND: The current World Health Organization classification indicates that a uterine smooth muscle tumor that cannot be histologically diagnosed as unequivocally benign or malignant should be termed "smooth muscle tumor of uncertain malignant potential" (STUMP).
  • DESIGN: The clinicopathologic features of 16 cases of STUMP that exhibited usual smooth muscle differentiation, diagnosed between 1992 and 2006 from 11 hospitals, were studied and classified into 4 subgroups using terminology and criteria described by Stanford investigators.
  • RESULTS: The tumors were classified as follows: 6 as "atypical leiomyoma with limited experience", 7 as "smooth muscle tumor of low malignant potential", 2 as "atypical leiomyoma, low risk of recurrence," and 1 as "mitotically active leiomyoma, limited experience."
  • Only 2 tumors recurred, at 15 and 51 months, respectively; both were atypical leiomyoma with limited experience (multifocal moderate-to-severe atypia, no tumor cell necrosis, and mitotic counts of 4 and 5 mitotic figures /10 high-power fields, respectively).
  • Both tumors had areas that were indistinguishable from benign leiomyoma and both had diffuse immunoreactivity for p16 and p53.
  • Six other tumors that had focal staining for these markers all had a benign outcome.
  • All the other patients were alive and disease-free.
  • CONCLUSIONS: This and other studies suggest that uterine tumors classified as STUMPs using criteria proposed by Stanford investigators are usually clinically benign but should be considered tumors of low malignant potential because they can occasionally recur, in some cases, years after hysterectomy.
  • [MeSH-major] Smooth Muscle Tumor / pathology. Uterine Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Cyclin-Dependent Kinase Inhibitor p16 / biosynthesis. Female. Humans. Immunohistochemistry. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / pathology. Receptors, Estrogen / biosynthesis. Receptors, Progesterone / biosynthesis. Tumor Suppressor Protein p53 / biosynthesis. Ubiquitin-Protein Ligases / biosynthesis

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19417585.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; 0 / Tumor Suppressor Protein p53; EC 6.3.2.19 / MIB1 ligase, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


26. Cyran CC, Fu Y, Raatschen HJ, Rogut V, Chaopathomkul B, Shames DM, Wendland MF, Yeh BM, Brasch RC: New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues. J Magn Reson Imaging; 2008 Mar;27(3):581-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues.
  • 100 cm(3)) and tumor fractional plasma volumes (%) based on a two-compartment kinetic model were performed for skeletal muscle and tumors.
  • 100 cm(3)) in normal soft tissue microvessels allowing successful differentiation (P < 0.05) of cancers from normal muscle.
  • PEG(12,000)-Gen4-(Gd-DOTA) leaked in tumors and in normal muscle (K(PS) = 51 +/- 26 and K(PS) = 21 +/- 18 microL/min .
  • The apparent threshold in effective molecular weight for a clear differentiation of cancer from normal muscle with no measurable leak in the muscle is between 194 and 323 kDa.
  • [MeSH-minor] Animals. Breast Neoplasms / diagnosis. Endothelium, Vascular. Female. Humans. Neoplasm Transplantation. Rats. Rats, Nude. Transplantation, Heterologous

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18219614.001).
  • [ISSN] 1053-1807
  • [Journal-full-title] Journal of magnetic resonance imaging : JMRI
  • [ISO-abbreviation] J Magn Reson Imaging
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 082923; United States / NCI NIH HHS / CA / R01 CA 103850
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Heterocyclic Compounds; 0 / Organometallic Compounds; 92923-44-9 / gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; AU0V1LM3JT / Gadolinium
  •  go-up   go-down


27. O'Neill CJ, McBride HA, Connolly LE, McCluggage WG: Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology; 2007 Jun;50(7):851-8
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
  • In this study, p16 immunohistochemical expression was assessed in a variety of uterine smooth muscle tumours, including usual leiomyomas, leiomyoma variants, smooth muscle tumours of uncertain malignant potential (STUMPs) and leiomyosarcomas.
  • The aim was to ascertain whether there are differences in p16 expression between these groups and whether p16 is of potential value in the assessment of problematic uterine smooth muscle neoplasms. p16 expression was also compared with that of p53 and MIB1.
  • CONCLUSIONS: p16 is overexpressed in uterine leiomyosarcomas compared with leiomyomas, benign leiomyoma variants and STUMPs, suggesting that p16 may be implicated in the pathogenesis of malignant uterine smooth muscle neoplasms. p16, in combination with p53 and MIB1, may be of value as an adjunct to morphological examination in the assessment of problematic uterine smooth muscle tumours, although further large-scale studies with follow-up are necessary to confirm this.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Leiomyoma / metabolism. Leiomyosarcoma / metabolism. Smooth Muscle Tumor / metabolism. Tumor Suppressor Protein p53 / metabolism. Ubiquitin-Protein Ligases / metabolism. Uterine Neoplasms / metabolism
  • [MeSH-minor] Cell Count. Female. Humans. Immunohistochemistry. Neoplasm Proteins / metabolism

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17543074.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Neoplasm Proteins; 0 / Tumor Suppressor Protein p53; EC 6.3.2.19 / MIB1 ligase, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


28. Ghezzi F, Cromi A, Bergamini V, Scarperi S, Bolis P, Franchi M: Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas. Surg Endosc; 2007 Nov;21(11):2081-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas.
  • BACKGROUND: Over the past decade an increasing demand for uterine-sparing treatment to manage symptomatic uterine myomas has become apparent in women's health care.
  • The purpose of this study was to evaluate the midterm outcomes of radiofrequency ablation (RFA) of uterine myomas in terms of durability of symptom control and level of health-related quality of life.
  • METHODS: Consecutive women with symptomatic uterine myomas, no plans for future pregnancy, and who declined hysterectomy were offered RFA ablation of uterine fibroids under laparoscopic guidance.
  • Improvement in myoma-related symptoms and impact on quality of life were assessed using a validated questionnaire (UFS-QOL).
  • RESULTS: The median number of myomas treated per patient was 1 (range = 1-3).
  • The median baseline volume of the dominant myoma was 76.8 cm3 (range = 14.8-332.8).
  • The median reduction in myoma volume was 68.8% and 77.9% at six months and one year, respectively.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Reprod. 1995 Jul;10 (7):1795-6 [8582982.001]
  • [Cites] Am J Obstet Gynecol. 2005 Mar;192(3):768-73 [15746670.001]
  • [Cites] J Gynecol Surg. 1993 Summer;9(2):95-9 [10171973.001]
  • [Cites] Am J Obstet Gynecol. 2004 Mar;190(3):639-43 [15041993.001]
  • [Cites] Am J Obstet Gynecol. 2002 Jun;186(6):1183-7 [12066095.001]
  • [Cites] Am J Obstet Gynecol. 2002 Aug;187(2):382-4 [12193929.001]
  • [Cites] Obstet Gynecol. 2002 Feb;99(2):290-300 [11814511.001]
  • [Cites] J Minim Invasive Gynecol. 2006 Mar-Apr;13(2):141-4 [16527717.001]
  • [Cites] Lancet Oncol. 2004 Sep;5(9):550-60 [15337485.001]
  • [Cites] Lancet. 1999 Dec 11;354(9195):2049-50 [10636374.001]
  • [Cites] Hum Reprod Update. 2000 Nov-Dec;6(6):595-602 [11129693.001]
  • [Cites] Appl Neurophysiol. 1976-1977;39(2):69-76 [1052287.001]
  • [Cites] J Am Assoc Gynecol Laparosc. 1995 Feb;2(2):175-9 [9050553.001]
  • [Cites] J Urol. 1961 Sep;86:321-9 [13763692.001]
  • [Cites] J Am Assoc Gynecol Laparosc. 1998 Feb;5(1):33-8 [9454874.001]
  • [Cites] J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):343-6 [16036195.001]
  • [Cites] Obstet Gynecol. 2002 Jul;100(1):8-17 [12100798.001]
  • [Cites] J Vasc Interv Radiol. 2003 Nov;14 (11):1395-9 [14605104.001]
  • [Cites] Fertil Steril. 2006 Jan;85(1):22-9 [16412721.001]
  • [Cites] J Reprod Med. 2001 Oct;46(10):870-4 [11725729.001]
  • [Cites] Hum Reprod. 2002 Oct;17(10):2737-41 [12351555.001]
  • [Cites] Fertil Steril. 2006 Jan;85(1):14-21 [16412720.001]
  • [Cites] Obstet Gynecol. 2005 Nov;106(5 Pt 1):933-9 [16260509.001]
  • [Cites] Cardiovasc Intervent Radiol. 2006 Jul-Aug;29(4):694-8 [16502165.001]
  • (PMID = 17514400.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


29. Nappi L, Matteo M, Giardina S, Rosenberg P, Indraccolo U, Greco P: Management of uterine giant myoma. Arch Gynecol Obstet; 2008 Jul;278(1):61-3
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of uterine giant myoma.
  • BACKGROUND: Giant myomas of the uterus are uncommon, particularly in developed countries.
  • CASE: This report illustrates a case of a woman with a bilobated giant myoma of the uterus weighed in total 27.7 kg.
  • CONCLUSIONS: The knowledge of the different clinical manifestation of these myomas may allow to face that with adequate perioperative care, in order to assure a carefully and successfully surgery, although sometimes a benign pathology may be not easy to suspect in a first time.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18066710.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


30. Bosev D, Dimitrov A: [Changes in uterine myoma dimentions during pregnancy]. Akush Ginekol (Sofiia); 2007;46(5):3-6
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Changes in uterine myoma dimentions during pregnancy].
  • The purpose of this study is to follow up the changes in the myoma dimentions during pregnancy (1st, 2nd and 3rd trimester).
  • The study is prospective and includes 90 pregnant women with myoma during the period 2002-2006.
  • If more than one myoma was diagnosed, the largest one was considered to be representative.
  • Our data show that the combination of myoma and pregnancy is more frequent with women over the age of 30 and it is more frequent with nullipares (63.2%).
  • Single myomas were more frequent with 58%, 48% of the myomas were intramural and 62% were located in the uterine corpus.
  • Our study shows that during the first trimester there is no change in the myomas dimentions in 35%-43% of the cases and during the second trimester there is no change of the myona dimentions in 50% of the cases.
  • During the third trimester there are only 5% of the myomas that change their dimentions.
  • We conclude, that the myomas, that enlarge during the first trimester, usually enlarge during the second trimester as well.
  • We found no decrease of the myoma dimentions during the third trimester.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17974174.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


31. Shibata K, Kajiyama H, Mizokami Y, Ino K, Nomura S, Mizutani S, Terauchi M, Kikkawa F: Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. Gynecol Oncol; 2005 Jul;98(1):11-8
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
  • Glucose is transported into the cell via facilitative glucose transporters, which are known to be members of a supergene family.
  • The authors evaluated P-LAP and GLUT4 expression in benign, borderline, and malignant ovarian epithelia.
  • METHODS: Histologic sections of formalin-fixed, paraffin-embedded specimens from 11 patients with benign serous or mucinous cystadenomas, 14 patients with serous or mucinous borderline tumors, and 80 patients with epithelial-ovarian adenocarcinomas (29 serous, 17 endometrioid, 14 mucinous, and 20 clear cell adenocarcinomas) were stained for P-LAP and GLUT4 using each polyclonal antibody.
  • RESULTS: P-LAP immunoreactivity was detected in 2 of 11 benign cystadenomas.
  • None of the 11 benign ovarian tumors showed any immunoreactivity for GLUT4.
  • [MeSH-major] Cystinyl Aminopeptidase / biosynthesis. Monosaccharide Transport Proteins / biosynthesis. Muscle Proteins / biosynthesis. Ovarian Neoplasms / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cell Growth Processes / physiology. Cell Line, Tumor. Epithelium / enzymology. Epithelium / metabolism. Female. Glucose Transporter Type 4. Humans. Middle Aged. Neoplasm Invasiveness. Ovarian Diseases / enzymology. Ovarian Diseases / metabolism. Ovarian Diseases / pathology. Transfection

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15907336.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Glucose Transporter Type 4; 0 / Monosaccharide Transport Proteins; 0 / Muscle Proteins; 0 / SLC2A4 protein, human; EC 3.4.11.3 / Cystinyl Aminopeptidase; EC 3.4.11.3 / leucyl-cystinyl aminopeptidase
  •  go-up   go-down


32. Makris N, Vomvolaki E, Mantzaris G, Kalmantis K, Hatzipappas J, Antsaklis A: Role of a bipolar resectoscope in subfertile women with submucous myomas and menstrual disorders. J Obstet Gynaecol Res; 2007 Dec;33(6):849-54
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of a bipolar resectoscope in subfertile women with submucous myomas and menstrual disorders.
  • METHODS: From January 2000 to December 2005, we studied 59 women of reproductive age with menorrhagia, submucous myomas and one or more infertility factors.
  • Fifteen of the 59 women displayed submucous myoma type O (intracavitary), 34 displayed submucous myoma type I (less than 50% within the myometrium) and the remaining 10 women displayed myoma type II (over 50% being within the myometrium).
  • The mean age and standard deviation of these patients was 34.6 +/- 4.4 years and the average size of myomas was 15 +/- 10 mm.
  • Treatment of these myomas was by hysteroscopic resection using a bipolar resectoscope.
  • The pregnancy rate was notably higher when the sole reason of subfertility was the presence of myoma (54.16%), and when the size of the myoma was equal to 2.5 cm (75%) or more.
  • CONCLUSION: The use of the bipolar resectoscope in hysteroscopic removal of small submucous myomas is shown to be both feasible and effective in controlling menorrhagia and increasing the pregnancy rate in subfertile women, when submucous myomas are the only reason of infertility.

  • MedlinePlus Health Information. consumer health - Female Infertility.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18001453.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


33. Daneliia GS, Paĭlodze MV, Dgebuadze MA, Matitashvili SG: [Morpho-functional parameters of the corpus luteum in healthy women and in patients of reproductive age with uterine myoma]. Morfologiia; 2006;129(1):76-80
Hazardous Substances Data Bank. PROGESTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Morpho-functional parameters of the corpus luteum in healthy women and in patients of reproductive age with uterine myoma].
  • Ovarian corpus luteum of menstruation at the stage of its peak activity was studied in normal women and in patients with proliferative uterine myoma using ultrasonography (intravaginal color Doppler imaging), laboratory analyses (progesterone and estrogen concentrations in peripheral blood) and morphological (histological, histochemical and morphometric) methods.
  • In patients with proliferative uterine myoma, the defective corpus luteum was detected, as indicated by the prevalence of small granulosa lutein cells, insignificant amount and uneven distribution of lipid inclusions in their cytoplasm, marked reduction of progesterone concentration in peripheral blood, unechogenicity, low degree of vascularization and increase in the value of resistance index of ovarian stromal arteries.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17201326.001).
  • [ISSN] 1026-3543
  • [Journal-full-title] Morfologii︠a︡ (Saint Petersburg, Russia)
  • [ISO-abbreviation] Morfologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 4G7DS2Q64Y / Progesterone
  •  go-up   go-down


34. Bodle JF, Duffy SR, Binney DM: Susceptibility of uterine myomas and endometrium to cryosurgery using a carbon dioxide cryosurgical probe in vitro. J Minim Invasive Gynecol; 2006 Nov-Dec;13(6):500-4
Hazardous Substances Data Bank. Carbon dioxide .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Susceptibility of uterine myomas and endometrium to cryosurgery using a carbon dioxide cryosurgical probe in vitro.
  • STUDY OBJECTIVE: To determine the effect of a 9-mm diameter carbon dioxide cryoprobe, the Endocryo, on myomas and endometrial/myometrial tissue in vitro.
  • DESIGN: Comparative laboratory study (Canadian Task Force classification II-2).
  • PATIENTS: Women with and without myomas, undergoing hysterectomy.
  • INTERVENTION: A single 5-minute freeze followed by an active thaw was applied to uterine myomas and endometrial/myometrial tissue in vitro.
  • MEASUREMENTS AND MAIN RESULTS: Endometrial/myometrial and uterine myoma temperature change was measured continuously during the cryosurgical procedure.
  • There was no significant difference in temperature change and depth of cell death between myomas and endometrial/myometrial tissue in vitro.
  • CONCLUSIONS: The Endocryo produces the same cryosurgical effect on both uterine myomas and endometrial/myometrial tissue in vitro, an important principal for future development of a clinically effective cryosurgical device for the treatment of menorrhagia in the presence of submucous myomas.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17097569.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 142M471B3J / Carbon Dioxide
  •  go-up   go-down


35. Jansen FW, de Kroon CD, van Dongen H, Grooters C, Louwé L, Trimbos-Kemper T: Diagnostic hysteroscopy and saline infusion sonography: prediction of intrauterine polyps and myomas. J Minim Invasive Gynecol; 2006 Jul-Aug;13(4):320-4
Hazardous Substances Data Bank. SODIUM CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic hysteroscopy and saline infusion sonography: prediction of intrauterine polyps and myomas.
  • STUDY OBJECTIVE: To compare the positive predictive value (PPV) of diagnostic hysteroscopy (DH) and saline infusion sonography (SIS) for the detection of myomas and polyps in patients with abnormal uterine bleeding.
  • DESIGN: All consecutive women referred to our University Hospital diagnosed with an intrauterine polyp or myoma by office DH or SIS were included in the study.
  • After hysteroscopic removal in an inpatient setting, histopathologic results were used as a gold standard to calculate PPV of SIS and DH. (Canadian Task Force classification II-3) SETTING: Tertiary referral center.
  • PATIENTS: Women in whom an intrauterine polyp or myoma was diagnosed either by DH or SIS MEASUREMENTS AND MAIN RESULTS: The PPVs of SIS and DH in the evaluation of intrauterine polyps and fibroids did not significantly differ.
  • CONCLUSIONS: Diagnostic hysteroscopy and saline infusion sonography are equivalent diagnostic tools for the detection of intrauterine myomas and polyps.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16825074.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 451W47IQ8X / Sodium Chloride
  •  go-up   go-down


36. Kulishova TV, Tabashnikova NA, Akker LV: [Efficacy of general magnetotherapy in conservative therapy of uterine myoma in women of reproductive age]. Vopr Kurortol Fizioter Lech Fiz Kult; 2005 Jan-Feb;(1):26-8
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Efficacy of general magnetotherapy in conservative therapy of uterine myoma in women of reproductive age].
  • Sixty women of the reproductive age with uterine myoma were divided into two groups.
  • Ultrasound investigation registered a reduction in the size of myoma nodes by 16.7% in the study group, while in the controls myoma size did not change (p < 0.05).
  • 1-year follow-up data for the study group demonstrated no cases of the myoma growth while 16.6% of the controls showed growth of myoma nodes, in 6.6% of them supravaginal myoma amputation was made for rapidly growing myoma.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15759473.001).
  • [ISSN] 0042-8787
  • [Journal-full-title] Voprosy kurortologii, fizioterapii, i lechebnoĭ fizicheskoĭ kultury
  • [ISO-abbreviation] Vopr Kurortol Fizioter Lech Fiz Kult
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia
  •  go-up   go-down


37. Durgun Y, Firat C, Miman MC, Kirimlioglu H: A rare benign laryngeal tumor: angiomyolipoma. J Craniofac Surg; 2010 Nov;21(6):1956-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare benign laryngeal tumor: angiomyolipoma.
  • Angiomyolipoma is a mesenchymal neoplasm containing adipose tissue, blood vessels, and smooth muscle fibers.
  • Arising most frequently in the kidney, the tumor may exceptionally be at the head and neck region.
  • The tumor was removed by an endolaryngeal approach.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21119467.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Huss WJ, Gray DR, Greenberg NM, Mohler JL, Smith GJ: Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res; 2005 Aug 1;65(15):6640-50
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
  • Putative prostate stem cells and prostate tumor stem cells in benign and malignant human prostate tissue, in primary human prostate xenografts, and in the transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse model of prostate cancer, are defined by expression of breast cancer resistance protein (BCRP), a marker of pluripotent hematopoietic, muscle, and neural stem cells, and by an absence of androgen receptor (AR) protein.
  • In both benign and malignant human prostate tissue, the rare epithelial cells that express BCRP and lack AR protein are localized in the basal cell compartment, survive androgen deprivation, and maintain proliferative potential in the hypoxic, androgen-deprived prostate.
  • Putative prostate tumor stem cells that express BCRP but not AR protein in TRAMP are the source of a BCRP-negative and AR-negative, Foxa2- and SV40Tag-expressing, transit amplifying compartment that progresses to the poorly differentiated carcinomas that arise rapidly after castration.
  • Therefore, BCRP expression isolates prostate stem/tumor stem cells from the prostate tissue microenvironment through constitutive efflux of androgen, protecting the putative tumor stem cells from androgen deprivation, hypoxia, or adjuvant chemotherapy, and providing the nidus for recurrent prostate cancer.

  • Genetic Alliance. consumer health - Prostate cancer.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. NOVOBIOCIN .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16061644.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA84296; United States / NCI NIH HHS / CA / P01 CA077739; United States / NCI NIH HHS / CA / CA77739; United States / NCI NIH HHS / CA / CA64851; United States / NIEHS NIH HHS / ES / ES07017; United States / NCI NIH HHS / CA / CA64865
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ABCG2 protein, human; 0 / Androgens; 0 / Indoles; 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / Receptors, Androgen; 17EC19951N / Novobiocin; CW5S8OP3VO / tryptoquivaline
  •  go-up   go-down


39. Brasileiro BF, Martins-Filho PR, Piva MR, da Silva LC, Nonaka CF, Miguel MC: Myofibroma of the oral cavity. A rare spindle cell neoplasm. Med Oral Patol Oral Cir Bucal; 2010 Jul;15(4):e596-600

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myofibroma of the oral cavity. A rare spindle cell neoplasm.
  • Myofibroma is an uncommon spindle cell neoplasm rarely found in oral cavity.
  • Misdiagnosis included benign and malignant spindle cell lesions of nerve tissue or smooth muscle origin, such as neurofibroma, leiomyoma and sarcomas.
  • Our report describes a solitary myofibroma of the tongue of a 23-year-old man with emphasis in clinical, histopathological and immunohistochemical features of this lesion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20038894.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


40. Román-Díaz J, Alayón-Laguer D, Fernández Nelson M, Luis B, Caceres-Perkins W, Conde-Sterling D: Rare benign breast tumor. Bol Asoc Med P R; 2010 Apr-Jun;102(2):50-2
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rare benign breast tumor.
  • We report the case of a female patient with an incidental finding at routine mammography evaluation which consisted of a benign spindle cell tumor, namely Breast Myofibroblastoma.
  • It is arranged in fascicles with interspersed broad bands of hyalinized collagen with variable immunohistochemical reactivity to desmin, vimentin, smooth muscle actin and CD 34.
  • It is important to recognize the benign nature of this neoplasm to prevent extensive mutilating surgical procedures.
  • [MeSH-major] Breast Neoplasms / pathology. Neoplasms, Muscle Tissue / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20939206.001).
  • [ISSN] 0004-4849
  • [Journal-full-title] Boletín de la Asociación Médica de Puerto Rico
  • [ISO-abbreviation] Bol Asoc Med P R
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Puerto Rico
  •  go-up   go-down


41. Maia H Jr, Casoy J, Pimentel K, Correia T, Athayde C, Cruz T, Coutinho EM: Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies. Contraception; 2008 Dec;78(6):479-85
Hazardous Substances Data Bank. PROGESTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies.
  • BACKGROUND: The study was conducted to evaluate vascular endothelial growth factor (VEGF), Cox-2 and aromatase expression in the endometrium of uteri with myomas and other associated pathologies.
  • STUDY DESIGN: Hysteroscopy was performed in 118 women of reproductive age with myomas and menorrhagia, 40 of whom were using a pill containing 75 mcg gestodene+30 mcg ethinylestradiol.
  • RESULTS: In patients with myomas and menorrhagia, associated pathologies such as adenomyosis, endometrial polyps and endometriosis were found in 32%, 12% and 17% of cases, respectively.
  • CONCLUSION: Endogenous progesterone or combined oral contraceptives are potent inhibitors of VEGF, aromatase and Cox-2 expression in the endometrium of patients with myomas and menorrhagia.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19014794.001).
  • [ISSN] 1879-0518
  • [Journal-full-title] Contraception
  • [ISO-abbreviation] Contraception
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contraceptives, Oral; 0 / Vascular Endothelial Growth Factor A; 4G7DS2Q64Y / Progesterone; EC 1.14.14.1 / Aromatase; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


42. Alborzi S, Ghannadan E, Alborzi S, Alborzi M: A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma. Fertil Steril; 2009 Aug;92(2):742-7
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma.
  • PATIENT(S): Of 152 women with symptomatic uterine myomas necessitating surgical intervention who wished to retain their uteri, 65 underwent laparoscopic uterine artery ligation and myomectomy (experimental group) and 87 received laparoscopic myomectomy only (control group).
  • In the experimental group, the recurrence of myoma was 6.2%, and 98.1% of the patients reported symptoms improvement; however, in the control group, these figures were 20.75% and 83.1%, respectively (statistically significant).
  • CONCLUSION(S): This study demonstrated the superiority of laparoscopic uterine artery ligation combined with myomectomy in treatment of symptomatic myomas.

  • MedlinePlus Health Information. consumer health - Female Infertility.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18692826.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Melli MS, Farzadi L, Madarek EO: Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression. Saudi Med J; 2007 Mar;28(3):445-50
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
  • OBJECTIVE: To investigate the effect of cabergoline (Dostinex, a dopamine agonist) on the myoma growth compared to Diphereline (a gonadotropin-releasing hormone agonist).
  • Fifty women with uterine myoma, who met the criteria of the study thoroughly, were randomly allocated into 2 equal groups to take either Diphereline or Cabergoline.
  • The tumor regressed significantly and volume reduction rate of individual tumor nodule varied from 46-53%.
  • The gonadotropin releasing hormone agonist group all responded to the treatment, and volume reduction rate of the individual tumor nodule varied from 21-97%.
  • The extent of tumor shrinkage was positively correlated to the number of nodules (p=0.881, p<0.005 and 0.701, p<0.005).
  • [MeSH-minor] Adult. Biopsy, Needle. Dose-Response Relationship, Drug. Drug Administration Schedule. Female. Follow-Up Studies. Humans. Infusions, Intravenous. Middle Aged. Neoplasm Staging. Prospective Studies. Risk Assessment. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17334477.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Ergolines; 33515-09-2 / Gonadotropin-Releasing Hormone; LL60K9J05T / cabergoline
  •  go-up   go-down


44. Marshburn PB, Matthews ML, Hurst BS: Uterine artery embolization as a treatment option for uterine myomas. Obstet Gynecol Clin North Am; 2006 Mar;33(1):125-44
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine artery embolization as a treatment option for uterine myomas.
  • A prospective study of "contemporaneous cohorts," which excluded patients who had sub-mucosal and pedunculated subserosal myomas, sought to compare quality of life measures and adverse events in patients who underwent UAE or hysterectomy.
  • Furthermore, hysterectomy eliminates uterine bleeding and the risk for recurrence of myomas.
  • After McLucas advocated that gynecologists learn the skill to perform UAE for managing symptomatic myomas, the Society of Interventional Radiology responded with a precautionary commentary on the level of technical proficiency that is necessary to maintain optimum results from UAE.
  • The gynecologist is likely to be the primary initial consultant to patients who present with complaints of symptomatic myomas.
  • Because some women may experience ovarian failure after UAE, additional studies to determine basal follicle-stimulating hormone and estradiol before and after the procedure may provide insight into UAE-induced follicle depletion.UAE is a unique new treatment for uterine myomas, and is no longer considered investigational for symptomatic uterine fibroids.
  • There is international recognition that data are needed from RCTs that compare UAE with surgical alternatives.
  • FIBROID should provide critical data for the assessment of safety and outcomes measures for women who receive UAE for symptomatic uterine myomas.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16504811.001).
  • [ISSN] 0889-8545
  • [Journal-full-title] Obstetrics and gynecology clinics of North America
  • [ISO-abbreviation] Obstet. Gynecol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 92
  •  go-up   go-down


45. Kanaoka Y, Yoshida C, Tsukioka M, Noriyuki M, Ishiko O: Ratio of directly necrotized volume to total volume of a submucosal myoma predicts shrinkage after microwave endometrial ablation. J Obstet Gynaecol Res; 2009 Aug;35(4):717-24
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ratio of directly necrotized volume to total volume of a submucosal myoma predicts shrinkage after microwave endometrial ablation.
  • AIM: To explore parameters relating to shrinkage of submucosal myomas after microwave endometrial ablation.
  • METHODS: Fourteen patients underwent microwave endometrial ablation at 2.45 GHz using a curved microwave applicator to treat menorrhagia caused by a submucosal myoma.
  • The size of myomas was measured on magnetic resonance images before, one month after, and six months after the operation.
  • The average radius r was defined as half of the size of the myoma measured in three dimensions.
  • The protrusion ratio alpha was defined as the ratio of the thickness of the protruding part of a myoma in the uterine cavity to the size of the myoma before the operation.
  • The ratio of the directly necrotized volume by microwave irradiation to the total volume (RODNeV) of preoperative myomas was calculated using the following formula:.
  • (1) where d is the depth of myoma tissue directly necrotized by microwave irradiation.
  • RESULTS: Two-dimensional plots showing shrinkage of submucosal myomas versus the RODNeV indicated that shrinkage at six months after microwave endometrial ablation depends on the RODNeV.
  • Myomas with a RODNeV greater than 0.17 had shrunk more than 50% at six months after the operation.
  • CONCLUSIONS: RODNeV is closely related to postoperative necrosis and shrinkage of the submucosal myoma after microwave endometrial ablation.
  • Prediction of the shrinkage rate of submucous myomas appears to be possible by calculating the RODNeV preoperatively.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19751333.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


46. Cramer SF, Mann L, Calianese E, Daley J, Williamson K: Association of seedling myomas with myometrial hyperplasia. Hum Pathol; 2009 Feb;40(2):218-25
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of seedling myomas with myometrial hyperplasia.
  • Myometrial hyperplasia (MMH) is a common structural variation characterized by irregular zones of increased myometrial cellularity, with increased nucleus-cell ratios; but to date, there has been only anecdotal evidence that it may give rise to myomas.
  • We studied the relationship of seedling myomas to MMH in 50 consecutive hysterectomies and found that most seedling myomas (44/63, 70%) arose in MMH--35 in inframucosal MMH, 3 in subserosal MMH, and 6 from intramural MMH.
  • Some seedling myomas were incompletely circumscribed, seeming to arise not only in but also from MMH.
  • We suggest that even seedlings in normal myometrium may arise not from normal myometrial smooth muscle cells but rather from myometaplasia in intramural stromal emboli, with hyperplastic and then neoplastic transformation.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18799191.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


47. Demirci F, Somunkiran A, Safak AA, Ozdemir I, Demirci E: Vaginal removal of prolapsed pedunculated submucosal myoma during pregnancy. Adv Ther; 2007 Jul-Aug;24(4):903-6
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal removal of prolapsed pedunculated submucosal myoma during pregnancy.
  • Pedunculated submucosal myomas are generally associated with infertility and are most often encountered during the preconception period.
  • This report describes a 38-y-old pregnant woman in whom a pedunculated submucosal myoma resulted in preterm labor and was successfully removed vaginally at 26 wk gestation.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17901039.001).
  • [ISSN] 0741-238X
  • [Journal-full-title] Advances in therapy
  • [ISO-abbreviation] Adv Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons: Myomas and reproductive function. Fertil Steril; 2008 Nov;90(5 Suppl):S125-30
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myomas and reproductive function.
  • The purpose of this Educational Bulletin is to examine the relationship between myomas and reproductive function and to review current methods for their management.
  • [MeSH-major] Myoma / physiopathology. Reproduction / physiology. Uterine Neoplasms / physiopathology

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19007608.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 33515-09-2 / Gonadotropin-Releasing Hormone
  • [Number-of-references] 72
  •  go-up   go-down


49. Parker WH: Uterine myomas: management. Fertil Steril; 2007 Aug;88(2):255-71
Hazardous Substances Data Bank. PROGESTERONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine myomas: management.
  • OBJECTIVE: To review the currently available literature regarding the current management alternatives available to women with uterine myomas.
  • DESIGN: Literature review of 198 articles pertaining to uterine myomas.
  • RESULT(S): Many advances have been made in the management of uterine myomas.
  • CONCLUSION(S): Many options are now available to women with uterine myomas.
  • The presently available literature regarding the treatment of myomas is summarized.
  • [MeSH-major] Myoma / therapy. Uterine Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17658523.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 33515-09-2 / Gonadotropin-Releasing Hormone; 4G7DS2Q64Y / Progesterone
  • [Number-of-references] 141
  •  go-up   go-down


50. Bierer S, Wülfing C, Bode ME, Pühse G, Brinkmann OA, Hertle L: [Bilateral renal angiomyolipomas with a thrombus in the inferior caval vein. Rare growth pattern of a benign tumor]. Urologe A; 2005 Dec;44(12):1469-72
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bilateral renal angiomyolipomas with a thrombus in the inferior caval vein. Rare growth pattern of a benign tumor].
  • [Transliterated title] Bilaterale renale Angiomyolipome mit Thrombus in der Vena cava inferior. Seltenes Wachstumsverhalten eines benignen Tumors.
  • Renal angiomyolipomas are mesenchymal tumors that are composed of fat tissue, smooth muscle cells and vessels.
  • These are benign tumors, but in rare cases they show a more aggressive growth pattern with invasion into the venous system but without revealing any signs of malignancy.
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Deep Vein Thrombosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 2002 Jan;93(1):48-51 [11842540.001]
  • [Cites] J Urol. 1992 Dec;148(6):1885-7 [1433629.001]
  • [Cites] Urology. 2002 Oct;60(4):695-6 [12385937.001]
  • [Cites] J Urol. 2004 Jan;171(1):102-5 [14665854.001]
  • [Cites] Rofo. 1999 Jun;170(6):605-7 [10420915.001]
  • [Cites] AJR Am J Roentgenol. 1995 Jul;165(1):198-9 [7785593.001]
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 1999 Aug;90(8):745-9 [10487052.001]
  • [Cites] J Urol. 1999 Jun;161(6):1900-1 [10332463.001]
  • [Cites] Prog Urol. 1997 Sep;7(4):637-9 [9410325.001]
  • [Cites] Acta Radiol. 1996 Nov;37(6):927-32 [8995468.001]
  • [Cites] J Urol. 1992 May;147(5):1356-8 [1569683.001]
  • [Cites] Nihon Hinyokika Gakkai Zasshi. 1994 Nov;85(11):1687-90 [7807779.001]
  • [Cites] Br J Urol. 1988 Jul;62(1):89-90 [3408879.001]
  • [Cites] J Urol. 1995 Apr;153(4):1205-7 [7869500.001]
  • [Cites] Semin Ultrasound CT MR. 1997 Apr;18(2):100-14 [9163829.001]
  • [Cites] Int J Urol. 1995 Nov;2(5):332-5 [8749954.001]
  • [Cites] J Urol. 1999 Oct;162(4):1371-2 [10492201.001]
  • [Cites] Urol Int. 2001;67(2):168-9 [11490215.001]
  • [Cites] Cardiovasc Intervent Radiol. 1994 May-Jun;17(3):152-4 [8087831.001]
  • [Cites] Scand J Urol Nephrol. 1997 Apr;31(2):189-91 [9165585.001]
  • [Cites] Urol Int. 2003;70(4):332-4 [12740503.001]
  • [Cites] Urology. 1997 Dec;50(6):975-7 [9426735.001]
  • [Cites] J Urol. 1982 Mar;127(3):528-9 [7062431.001]
  • [Cites] Br J Urol. 1994 Sep;74(3):383-5 [7953277.001]
  • [Cites] J Urol. 2003 Sep;170(3):918-9 [12913732.001]
  • [Cites] Urol Radiol. 1987;9(3):152-4 [3326240.001]
  • [Cites] Br J Urol. 1998 May;81(5):773-4 [9634065.001]
  • [Cites] Am J Surg Pathol. 1991 Nov;15(11):1083-8 [1928559.001]
  • [Cites] J Urol. 2002 Oct;168(4 Pt 1):1315-25 [12352384.001]
  • (PMID = 16133230.001).
  • [ISSN] 0340-2592
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


51. Bivalacqua TJ, Loeb S, Pierorazio PM, Schoenberg MP, Partin AW, Guzzo TJ: Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer? Urol Int; 2010;85(4):466-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is prostate-specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer?
  • BACKGROUND: Radical cystoprostatectomy (RCP) remains the gold standard for the treatment of muscle-invasive bladder cancer.
  • There are limited data regarding the clinical impact and detection of PSA following complete prostatectomy or the need to monitor serum PSA in patients with benign prostate pathology at time of RCP.
  • CONCLUSIONS: Serum PSA should remain undetectable for men with benign prostate pathology undergoing complete prostatectomy at the time of RCP.
  • Elevated serum PSA following complete RCP in men with bladder cancer and pathologically confirmed benign prostate findings is rare.
  • If the serum PSA is undetectable 3 months after RCP with benign prostate pathology, there is no need for continued PSA monitoring.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Baltimore. Humans. Male. Middle Aged. Neoplasm Invasiveness. Predictive Value of Tests. Time Factors. Treatment Outcome


52. Metta H, Corti M, Redini L, Dure R, Campitelli AM, Narbaitz M: Endobronchial leiomyoma: an unusual non-defining neoplasm in a patient with AIDS. Rev Inst Med Trop Sao Paulo; 2009 Jan-Feb;51(1):53-5
MedlinePlus Health Information. consumer health - HIV/AIDS.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endobronchial leiomyoma: an unusual non-defining neoplasm in a patient with AIDS.
  • Smooth muscle neoplasms are more frequent in human immunodeficiency infected children than in HIV seropositive adults.
  • Endobronchial leiomyoma is a rare benign tumor in HIV infected adult patients.
  • Our report suggests that smooth muscle tumors as leiomyoma should be included in the differential diagnosis of endobronchial masses in AIDS patients.

  • Genetic Alliance. consumer health - AIDS-HIV.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19229392.001).
  • [ISSN] 1678-9946
  • [Journal-full-title] Revista do Instituto de Medicina Tropical de São Paulo
  • [ISO-abbreviation] Rev. Inst. Med. Trop. Sao Paulo
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


53. Ferrero S, Abbamonte LH, Giordano M, Parisi M, Ragni N, Remorgida V: Uterine myomas, dyspareunia, and sexual function. Fertil Steril; 2006 Nov;86(5):1504-10
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uterine myomas, dyspareunia, and sexual function.
  • OBJECTIVE: To determine the prevalence of deep dyspareunia (DD) and characteristics of sexual life in women with uterine myomas.
  • PATIENT(S): Three hundred seven sexually active premenopausal women who underwent surgery because of uterine myomas (group M, n = 132), uterine myomas and ovarian cysts (group MC, n = 84), ovarian cysts (group C, n = 67), and tubal sterilization (group S, n = 24).
  • Exclusion criteria were as follows: endometriosis, pelvic inflammatory disease, interstitial cystitis, and preoperative treatment with GnRH analogues.
  • INTERVENTION(S): Before surgery, patients underwent transvaginal ultrasound; number and characteristics of myomas were recorded.
  • No significant difference was observed in DD prevalence and pain intensity according to the number, position, and size of myomas.
  • Deep dyspareunia intensity was higher in women with fundal and anterior myomas than in those with other myoma positions.
  • CONCLUSION(S): Women with uterine myomas do not have increased prevalence or severity of DD; their sexual function is not impaired.


54. Paul PG, Koshy AK: Multiple peritoneal parasitic myomas after laparoscopic myomectomy and morcellation. Fertil Steril; 2006 Feb;85(2):492-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple peritoneal parasitic myomas after laparoscopic myomectomy and morcellation.
  • We describe multiple parasitic myomas visualized on laparoscopy in a woman who had a previous laparoscopic myomectomy.
  • Location of the myomas suggests morcellation as a contributing factor.
  • [MeSH-major] Laparoscopy / adverse effects. Myoma / pathology. Myoma / surgery. Peritoneal Neoplasms / pathology. Peritoneal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16595233.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Hakverdi S, Dolapçioğlu K, Güngören A, Yaldiz M, Hakverdi AU: Multiple uterine angioleiomyomas mimicking an ovarian neoplasm: a case report. Eur J Gynaecol Oncol; 2009;30(5):592-4
MedlinePlus Health Information. consumer health - Uterine Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple uterine angioleiomyomas mimicking an ovarian neoplasm: a case report.
  • Angioleiomyoma is a rare benign neoplasm that originates from smooth muscle cells and contains thick-walled blood vessels.
  • On pathologic examination of the specimen, the tumor was diagnosed as an angioleiomyoma.
  • Here, we present a case of giant-multiple uterine angioleiomyomas mimicking an ovarian neoplasm.
  • [MeSH-major] Angiomyoma / diagnosis. Angiomyoma / pathology. Ovarian Neoplasms / diagnosis. Uterine Diseases / diagnosis. Uterine Diseases / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19899426.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


56. Gomez-Moyano E, Vera-Casaño A, Martinez-Garcia S, Sanz-Trelles A, Crespo-Erchiga V: Two cases of dermatomyofibroma (plaque-like dermal fibromatosis). Int J Dermatol; 2010 Aug;49(8):914-7
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Dermatomyofibroma is a rare but distinct benign cutaneous mesenchymal neoplasm of fibroblastic/myofibroblastic differentiation.
  • CASE REPORT: We present a) a new case of dermatomyofibroma in an 11-month-old male infant, the youngest case reported to date, and b) the second reported case of a giant annular dermatomyofibroma, measuring 10 cm × 6 cm, in a 52-year-old woman.
  • In both cases the spindle cells stained positive for smooth muscle actin and the elastic fibers were increased and fragmented.
  • CONCLUSION: Dermatologists and pediatricians should be aware of this benign entity in order to avoid unnecessary treatment.
  • [MeSH-major] Dermis / pathology. Fibroblasts / pathology. Histiocytoma, Benign Fibrous / diagnosis. Muscle, Smooth / pathology. Skin Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 The International Society of Dermatology.
  • (PMID = 21174375.001).
  • [ISSN] 1365-4632
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Schwartz PE, Kelly MG: Malignant transformation of myomas: myth or reality? Obstet Gynecol Clin North Am; 2006 Mar;33(1):183-98, xii
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant transformation of myomas: myth or reality?
  • The possibility that a fibroid may actually be a smooth muscle tumor of uncertain malignant potential or a leiomyosarcoma often dictates the clinical management of rapidly growing fibroids.
  • The clinician must be aware that the infrequent occurrence of uterine leiomyosarcomas makes it difficult to establish absolutely firm recommendations for the diagnosis and management of this disease, particularly with regard to fertility preservation.
  • Nevertheless, this article addresses major issues that a clinician might face in the evaluation of a smooth muscle tumor of the uterus that clinically may be malignant.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16504815.001).
  • [ISSN] 0889-8545
  • [Journal-full-title] Obstetrics and gynecology clinics of North America
  • [ISO-abbreviation] Obstet. Gynecol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Buyukkurt S, Yuksel A, Seydaoglu G, Has R, Kadayifci O: The effect of amniocentesis on preterm delivery rate in women with uterine myoma. Clin Exp Obstet Gynecol; 2010;37(1):33-6
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effect of amniocentesis on preterm delivery rate in women with uterine myoma.
  • OBJECTIVES: To evaluate the effect of genetic amniocentesis on the preterm delivery rate in women with uterine myoma.
  • RESULTS: During the study 14,579 pregnant women were examined and 234 had complications of uterine myomas (1.61%).
  • The results revealed that multifocal fibroids in relation to the myometrium, uterine myoma subjacent to the placenta, total myoma volume greater than 150 cm3 are statistically significant independent risk factors for preterm delivery, while amniocentesis was not found to be an independent risk factor for preterm delivery.
  • CONCLUSIONS: Although having uterine myoma is a fairly known cause of preterm delivery, second trimester genetic amniocentesis does not seem to have any additional adverse effect on the preterm delivery rate in women with uterine myomas.
  • [MeSH-major] Amniocentesis. Myoma / epidemiology. Premature Birth / epidemiology. Uterine Neoplasms / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20420278.001).
  • [ISSN] 0390-6663
  • [Journal-full-title] Clinical and experimental obstetrics & gynecology
  • [ISO-abbreviation] Clin Exp Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


59. Dane B, Dane C, Basaran S, Erginbas M, Cetin A: Vaginal Schwannoma in a case with uterine myoma. Ann Diagn Pathol; 2010 Apr;14(2):137-9
MedlinePlus Health Information. consumer health - Vaginal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal Schwannoma in a case with uterine myoma.
  • We report a case of vaginal schwannoma associated with uterine myoma.
  • A 52-year-old woman presented with lower abdominal pain and menorrhagia for a duration of 6 months.
  • At sonographic examination, the patient was found to have uterine myomas and a solid mass measuring 5x4.5 cm beneath the vaginal wall.
  • At laparotomy, the uterus with myoma was removed using our standard operation procedures.
  • The tumor cells were vimentin (+), desmin (-), smooth muscle alpha-actin (-), HMB-45 (-), MART-1 (-) and S-100 (+).
  • The differential diagnosis of a mass in the vagina includes also schwannomas.
  • Immunocytochemical labeling of the tumor cells is essential.

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20227020.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Ciavattini A, Tsiroglou D, Tranquilli AL, Litta P: Laparoscopic versus ultraminilaparotomic myomectomy for the treatment of large uterine myomas. Acta Obstet Gynecol Scand; 2010;89(1):151-5
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic versus ultraminilaparotomic myomectomy for the treatment of large uterine myomas.
  • We compared short-term surgical outcomes of laparoscopic and ultraminilaparotomic procedures for the treatment of large uterine myomas in a retrospective matched-control study (Canadian Task Force classification II-2) of 32 women with large myomas who underwent laparoscopic myomectomy and 32 women who had ultraminilaparotomic myomectomy (< or =4 cm incision).
  • Laparoscopic myomectomy seems to be the preferable approach for the treatment of large myomas of > or =5 cm, providing a more rapid recovery compared to the ultraminilaparotomic approach.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19878068.001).
  • [ISSN] 1600-0412
  • [Journal-full-title] Acta obstetricia et gynecologica Scandinavica
  • [ISO-abbreviation] Acta Obstet Gynecol Scand
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


61. Funaki K, Fukunishi H, Funaki T, Kawakami C: Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol; 2007 Sep-Oct;14(5):616-21
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction.
  • STUDY OBJECTIVE: To clarify the volume change ratio of uterine myomas treated with magnetic resonance-guided focused ultrasound surgery (MRgFUS), in relation to the signal intensity of T(2)-weighted magnetic resonance (MR) images.
  • DESIGN: Prospective study (Canadian Task Force classification II-3).
  • PATIENTS: Forty-eight myomas in 35 patients were followed up with MR images 6 months after MRgFUS, and 23 myomas in 17 patients were followed up 12 months after MRgFUS.
  • Before treatment, the myomas were classified into 3 types on the basis of the signal intensity of T(2)-weighted MR images as follows: Type 1, low intensity; type 2, intermediate intensity; type 3, high intensity.
  • MEASUREMENTS AND MAIN RESULTS: MRgFUS produced a greater volume reduction in type 1 and type 2 myomas than in type 3 myomas.
  • Nonperfused areas always diminished in the period after MRgFUS; however, the volume change was affected by the volume change ratio of perfused areas inside the treated myomas.
  • CONCLUSION: At present, type 3 myomas should be exempted from the application of MRgFUS, because the nonperfused ratio immediately after the procedure was small compared with that in type 1 and type 2 myomas, and the subsequent volume change was unfavorable.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17848324.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Jindabanjerd K, Taneepanichskul S: The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women. J Med Assoc Thai; 2006 Oct;89 Suppl 4:S147-51
Hazardous Substances Data Bank. LEVONORGESTREL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of levonorgestrel - IUD in the treatment of uterine myoma in Thai women.
  • OBJECTIVE: This study was designed to evaluate the potential usefulness of the levonorgestrel-releasing intrauterine device (LNG - IUD ; Mirena) in treating women with uterine myomas.
  • SUBJECTS: Sixteen women with uterine myomas who intended to receive treatment with the LNG IUD.
  • MAIN OUTCOME MEASURES: Myoma and Uterine volume, menstrual blood loss assessed with pictorial blood loss assessment charts and hematocrit.
  • RESULTS: Use of the LNG IUD was associated with a statistically significant reduction in the total myoma volume, average uterine size and marked reduction in menstrual blood loss.
  • After 6 months of use, the median total myoma volume decreased from 19.82 mL to 11.63 mL (p < 0.05), median pictorial blood loss assessment chart score declined from 89 to 3 (p < 0.05).
  • CONCLUSION: The LNG IUD was associated with a profound reduction in myoma and uterine volume.
  • For women with myomas of this size, the LNG IUD provides effective medical treatment of bleeding.
  • [MeSH-major] Contraceptives, Oral, Synthetic / therapeutic use. Intrauterine Devices, Medicated. Levonorgestrel / therapeutic use. Myoma / drug therapy. Uterine Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17726816.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  • [Chemical-registry-number] 0 / Contraceptives, Oral, Synthetic; 5W7SIA7YZW / Levonorgestrel
  •  go-up   go-down


63. Liu WM, Wang PH, Chou CS, Tang WL, Wang IT, Tzeng CR: Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas. Fertil Steril; 2007 Feb;87(2):356-61
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas.
  • OBJECTIVE: To evaluate the therapeutic efficacy of laparoscopic uterine artery occlusion combined with myomectomy through a minilaparotomy in the treatment of recurrent uterine myomas, compared with myomectomy alone.
  • PATIENT(S): Eighty-two women with symptomatic, recurrent myomas warranting surgical treatment, who expressed a strong desire to retain their uterus.
  • MAIN OUTCOME MEASURE(S): The efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas was measured by comparing blood loss, need for blood transfusion, postoperative febrile morbidity, recurrence rate of the uterine myomas, and fertility rate in the treatment (group I) and control (group II) groups.
  • The recurrence rate of uterine myomas was 5.8% (3 of 52) in group I and 36.7% (11 of 30) in group II during an average follow-up period of 42.5 months.
  • CONCLUSION(S): This study has demonstrated the superiority of laparoscopic uterine artery occlusion when combined with repeat myomectomy in treating recurrent symptomatic myomas.
  • [MeSH-major] Laparoscopy / methods. Laparotomy / methods. Leiomyoma / surgery. Neoplasm Recurrence, Local / surgery. Uterine Neoplasms / surgery. Uterus / blood supply. Uterus / surgery

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Fertil Steril. 2007 Sep;88(3):758-9; author reply 759 [17681320.001]
  • (PMID = 17069812.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


64. Miller CE: Unmet therapeutic needs for uterine myomas. J Minim Invasive Gynecol; 2009 Jan-Feb;16(1):11-21
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unmet therapeutic needs for uterine myomas.
  • Uterine myomas may develop in many women, but only become clinically significant in about one third of the affected population.
  • Although uterine myomas are most often benign, they are associated with debilitating symptoms and commonly result in hysterectomy.
  • Current treatments for uterine myomas include pharmacologic therapies, delivery of focused energy, alteration of uterine vascular supply, or surgical procedures.
  • Factors such as the woman's desire for future pregnancy, the importance of uterine preservation, symptom severity, and tumor characteristics direct the choice of therapeutic approach.
  • The ideal treatment will have the following characteristics: easy to perform, minimally invasive, cost effective, preserves fertility, preserves the uterus, efficacious, acceptable tolerability and durability, and low incidence of myoma recurrence.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19110181.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 110
  •  go-up   go-down


65. Rammeh-Rommani S, Mokni M, Stita W, Trabelsi A, Hamissa S, Sriha B, Tahar-Yacoubi M, Korbi S: [Uterine smooth muscle tumors: retrospective epidemiological and pathological study of 2760 cases]. J Gynecol Obstet Biol Reprod (Paris); 2005 Oct;34(6):568-71
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Uterine smooth muscle tumors: retrospective epidemiological and pathological study of 2760 cases].
  • [Transliterated title] Les tumeurs musculaires lisses de l'utérus: étude épidémiologique et anatomo-pathologique rétrospective de 2760 cas.
  • INTRODUCTION: Smooth muscle tumors of the uterus are frequent.
  • Most of them are benign.
  • Some leiomyomas may have unusual morphologic features difficult to distinguish from leiomyosarcoma.
  • OBJECTIVES: The purpose of our work is to study cases of leiomyosarcomas, cellular leiomyoma, atypical leiomyoma and mitotically active leiomyoma among a large series of uterine smooth muscle tumors.
  • MATERIALS AND METHODS: We reviewed retrospectively 2760 uterine smooth muscle tumors.
  • The slides were reviewed and the tumors reclassified according to the criteria of the WHO 2003 classification.
  • RESULTS: Review of the slides demonstrated: 12 mitotically active leiomyomas, 18 cellular leiomyomas, 20 atypical leiomyomas, 16 leiomysarcomas, only one case of smooth muscle tumor of uncertain malignant potential.
  • [MeSH-minor] Female. Humans. Leiomyoma / epidemiology. Leiomyoma / pathology. Neoplasm Recurrence, Local. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16208199.001).
  • [ISSN] 0368-2315
  • [Journal-full-title] Journal de gynécologie, obstétrique et biologie de la reproduction
  • [ISO-abbreviation] J Gynecol Obstet Biol Reprod (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


66. Tsai CY, Wei FC, Chang YL, Chen YY, Chen CT: Vastus lateralis muscle flap used for reconstruction of the maxilla after radical resection of recurrent ameloblastoma. Chang Gung Med J; 2006 May-Jun;29(3):331-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vastus lateralis muscle flap used for reconstruction of the maxilla after radical resection of recurrent ameloblastoma.
  • Maxillary ameloblastoma is a benign odontogenic neoplasm.
  • Simultaneous reconstruction was performed with an iliac crest bone graft for the orbital floor, and a vastus lateralis muscle flap for obliteration of the maxillary sinus and repair the oral and nasal cavities.
  • The transferred vastus lateralis muscle already had spontaneous mucosalization over its surface two weeks after surgery.
  • The use of a single vastus lateralis muscle flap to repair both oral and nasal cavities is advantageous.
  • The conventional iliac bone graft supported by a well vascularized muscle eventually survived and provided a good functional and cosmetic result.
  • [MeSH-major] Ameloblastoma / surgery. Maxilla / surgery. Maxillary Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Surgical Flaps

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16924896.001).
  • [ISSN] 2072-0939
  • [Journal-full-title] Chang Gung medical journal
  • [ISO-abbreviation] Chang Gung Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


67. Parfitt JR, Bella AJ, Izawa JI, Wehrli BM: Malignant neoplasm of perivascular epithelioid cells of the liver. Arch Pathol Lab Med; 2006 Aug;130(8):1219-22
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant neoplasm of perivascular epithelioid cells of the liver.
  • Neoplasms of perivascular epithelioid cells (PEComas) have in common the coexpression of muscle and melanocytic immunohistochemical markers.
  • Although this group includes entities with distinct clinical features, such as angiomyolipoma, clear cell sugar tumor of the lung, and lymphangioleiomyomatosis, similar tumors have been documented in an increasing diversity of locations.
  • While most reported PEComas have behaved in a benign fashion, malignant PEComas have occasionally been documented.
  • We present a case of hepatic PEComa with benign histologic features, which nonetheless presented with metastases to multiple sites nearly 9 years later.
  • This case represents the second documented malignant PEComa of the liver, as well as the longest follow-up of a surviving patient with a malignant PEComa, emphasizing both the need for criteria that more accurately predict the behavior of PEComas and the necessity of long-term follow-up of patients with PEComas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879028.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Holub Z, Mára M: [Myomas, fertility and pregnancy]. Ceska Gynekol; 2008 Oct;73(5):307-13
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Myomas, fertility and pregnancy].
  • OBJECTIVE: The objective of this paper is give to guideline to the management of myoma, fertility and pregnancy.


69. Murakami T, Hayasaka S, Terada Y, Yuki H, Tamura M, Yokomizo R, Nabeshima H, Yaegashi N, Okamura K: Predicting outcome of one-step total hysteroscopic resection of sessile submucous myoma. J Minim Invasive Gynecol; 2008 Jan-Feb;15(1):74-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Predicting outcome of one-step total hysteroscopic resection of sessile submucous myoma.
  • STUDY OBJECTIVE: To analyze variables for successful 1-step hysteroscopic myomectomies of sessile submucous myomas.
  • DESIGN: Retrospective case-control study. (Canadian Task Force classification II-2).
  • PATIENTS: Twenty-eight patients with sessile submucous myomas and menorrhagia, infertility, or both.
  • First, we scraped and/or vaporized intrauterine dome of myoma until top of myoma was even with level of wall of cavity.
  • Finally, the newly raised myoma dome was sectioned or vaporized electrosurgically only within the space of the intrauterine cavity and/or was separated mechanically from healthy myometrium without electrosurgery.
  • MEASUREMENTS AND MAIN RESULTS: Submucous myomas in 16 (57.1%) patients were completely removed after 1 surgery.
  • By logistic regression analysis, thickness of outer myometrial layer of myoma node (OR 3.06, p = .02), myoma size (OR 0.86, p = .04), and intramural extension degree (OR 0.91, p = .03) were significantly associated with outcome of complete resection.
  • CONCLUSION: Thickness of outer myometrial layer of myoma node, myoma size, and intramural extension degree predicted outcome of 1-step hysteroscopic myomectomy.
  • The chance of performing successful surgery increased with increased thickness of outer myometrial layer of myoma, and decreased with larger myomas and greater degrees of intramural extension.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18262148.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Schweppe KW: Long-term use of progestogens--effects on endometriosis, adenomyosis and myomas. Gynecol Endocrinol; 2007 Oct;23 Suppl 1:17-21
MedlinePlus Health Information. consumer health - Endometriosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term use of progestogens--effects on endometriosis, adenomyosis and myomas.
  • Oral progestins, without an estrogen component, have been reported to be effective in the treatment of endometriosis, but not adenomyosis or myomas.
  • Besides the importance of estrogens for the development and growth of endometriosis and myomas, progesterone seems to play an important role in the modulation of mitotic activity, local growth factors and growth factor receptors, as well as other paracrine mechanisms.
  • Effective new therapies for endometriosis have been introduced during the last 30 years and progestins now have a place in the symptomatic management of pain, bleeding and other symptoms caused by endometriosis, adenomyosis or myoma, particularly when long-term medication is indicated or when repeated courses of treatment are acceptable.
  • [MeSH-major] Endometriosis / drug therapy. Myoma / drug therapy. Progestins / administration & dosage

  • Genetic Alliance. consumer health - Adenomyosis.
  • Genetic Alliance. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17943535.001).
  • [ISSN] 1473-0766
  • [Journal-full-title] Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • [ISO-abbreviation] Gynecol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Progestins
  • [Number-of-references] 33
  •  go-up   go-down


71. Sutter MA, Eggspuehler A, Grob D, Porchet F, Jeszenszky D, Dvorak J: Multimodal intraoperative monitoring (MIOM) during 409 lumbosacral surgical procedures in 409 patients. Eur Spine J; 2007 Nov;16 Suppl 2:S221-8
MedlinePlus Health Information. consumer health - Spine Injuries and Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multimodal intraoperative monitoring (MIOM) during 409 lumbosacral surgical procedures in 409 patients.
  • A prospective study on 409 patients who received multimodel intraoperative monitoring (MIOM) during lumbosacral surgical procedures between March 2000 and December 2005 was carried out.
  • The objective of this study was to determine the sensitivity and specificity of MIOM techniques used to monitor conus medullaris, cauda equina and nerve root function during lumbosacral decompression surgery.
  • MIOM has increasingly become important to monitor ascending and descending pathways, giving immediate feedback information regarding any neurological deficit during the decompression and stabilisation procedure in the lumbosacral region.
  • A total of 409 consecutive patients with lumbosacral spinal stenosis with or without instability were monitored by MIOM during the entire surgical procedure.
  • The sensitivity of MIOM applied during decompression and fusion surgery of the lumbosacral region was calculated as 90%, and the specificity was calculated as 99.7%.
  • On the basis of the results of this study, MIOM is an effective method of monitoring the conus medullaris, cauda equina and nerve root function during surgery at the lumbosacral junctions and might reduce postoperative surgical-related complications and therefore improve the long-term results.
  • [MeSH-major] Lumbosacral Region / surgery. Monitoring, Intraoperative / methods. Spinal Diseases / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Orthop Scand. 1999 Aug;70(4):329-34 [10569260.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Jun 1;25(11):1437-46 [10828927.001]
  • [Cites] J Neurosurg. 2000 Jul;93(1 Suppl):45-52 [10879757.001]
  • [Cites] Spine (Phila Pa 1976). 2002 Jul 1;27(13):1444-50 [12131744.001]
  • [Cites] Spine (Phila Pa 1976). 1993 Dec;18(16):2401-7 [8303440.001]
  • [Cites] Eur Spine J. 2007 Nov;16 Suppl 2:S162-70 [17665225.001]
  • [Cites] J Spinal Disord. 1996 Feb;9(1):8-16 [8727451.001]
  • [Cites] J Bone Joint Surg Br. 1997 Mar;79(2):183-9 [9119839.001]
  • [Cites] J Neurosurg. 1997 Sep;87(3):397-402 [9285605.001]
  • [Cites] Spine (Phila Pa 1976). 1997 Dec 15;22(24):2813-22 [9431617.001]
  • [Cites] J Neurosurg. 1999 Oct;91(2 Suppl):186-92 [10505503.001]
  • [Cites] Spine (Phila Pa 1976). 1995 Jun 15;20(12):1375-9 [7676335.001]
  • (PMID = 17912559.001).
  • [ISSN] 0940-6719
  • [Journal-full-title] European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
  • [ISO-abbreviation] Eur Spine J
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC2072902
  •  go-up   go-down


72. Solè LI, Rosato G, Bolino MC, Bassotti G: An unusual cause of obstructed defecation. Tech Coloproctol; 2009 Sep;13(3):247-9
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Obstructed defecation is one subtype of constipation, and may be due to functional or mechanical causes.
  • Here, we report an unusual cause, never described before, of obstructed defecation due to a large uterine myoma that reverted to normal bowel habits after surgery.
  • [MeSH-minor] Chronic Disease. Constipation / diagnosis. Constipation / etiology. Defecation / physiology. Female. Follow-Up Studies. Humans. Hysterectomy / methods. Magnetic Resonance Spectroscopy. Manometry / methods. Middle Aged. Recovery of Function. Risk Assessment. Severity of Illness Index. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 1997 Nov;84(11):1555-8 [9393278.001]
  • [Cites] J Clin Gastroenterol. 1990 Dec;12(6):690-2 [2266249.001]
  • [Cites] Actas Urol Esp. 1999 Nov-Dec;23(10):895-7 [10670135.001]
  • [Cites] Intern Med. 2008;47(8):809 [18421206.001]
  • [Cites] BMJ. 2004 Feb 14;328(7436):393-6 [14962877.001]
  • [Cites] Am J Gastroenterol. 2003 Feb;98 (2):399-411 [12591061.001]
  • [Cites] Clin Exp Obstet Gynecol. 2007;34(3):188-9 [17937099.001]
  • [Cites] QJM. 1997 Aug;90(8):545-50 [9327034.001]
  • [Cites] Gastroenterology. 2005 May;128(5):1199-210 [15887104.001]
  • [Cites] Aust N Z J Obstet Gynaecol. 1999 Aug;39(3):384-6 [10554963.001]
  • [Cites] J Gastroenterol Hepatol. 2006 Apr;21(4):638-46 [16677147.001]
  • [Cites] Obstet Gynecol. 2003 May;101(5 Pt 2):1088-91 [12738111.001]
  • [Cites] Arch Ital Urol Androl. 1998 Sep;70(4):163-4 [9823661.001]
  • [Cites] Arch Gynecol Obstet. 2008 Jul;278(1):61-3 [18066710.001]
  • [Cites] Clin Radiol. 2008 Jan;63(1):18-26 [18068787.001]
  • [Cites] Colorectal Dis. 2003 Jul;5(4):280-7 [12814403.001]
  • (PMID = 19609740.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


73. Østergaard JR, Smith T, Stausbøl-Grøn B: Intraneural perineurioma of the sciatic nerve in early childhood. Pediatr Neurol; 2009 Jul;41(1):68-70
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intraneural perineurioma is an uncommon benign neoplasm characterized by focal perineural cell proliferation.
  • [MeSH-minor] Child, Preschool. Diagnosis, Differential. Electromyography. Humans. Magnetic Resonance Imaging. Male. Muscle, Skeletal / pathology. Muscle, Skeletal / physiopathology. Pelvis / pathology. Peroneal Neuropathies / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19520281.001).
  • [ISSN] 1873-5150
  • [Journal-full-title] Pediatric neurology
  • [ISO-abbreviation] Pediatr. Neurol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Lin CC, Ou MC, Hsiao SM, Lin HH: Myomectomy through the uterine cervix using forceps under sonographic guidance. Ultrasound Obstet Gynecol; 2009 Feb;33(2):228-31
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To evaluate the feasibility of a novel method of forceps myomectomy under sonographic guidance.
  • METHODS: Between June 2005 and August 2006, we performed a prospective study to evaluate the feasibility of forceps myomectomy under sonographic guidance in patients with submucosal myomas.
  • Patients were enrolled into the study if, on transvaginal sonographic or hysteroscopic examination, their myomas were found to have an intramural extension < 75%, absence of 'sinking' and a mean diameter < 8 cm.
  • RESULTS: There were 28 patients with submucosal myomas including Types 0 (n = 18), 1 (n = 6) and 2 (n = 4).
  • In 26/28 (92.8%; 95% CI, 82.6-100) patients the myomas were removed completely.
  • CONCLUSIONS: In our experience, this novel method of forceps myomectomy is feasible for the removal of Type 0 and Type 1 submucosal myomas as well as selected Type 2 myomas.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19053164.001).
  • [ISSN] 1469-0705
  • [Journal-full-title] Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • [ISO-abbreviation] Ultrasound Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


75. Meshkova IE, Volkova AV, Semenov II: [Features of ultrasound diagnosis of non-epithelial ovarian carcinoma]. Vopr Onkol; 2007;53(3):345-51
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ultrasound examination using color Doppler imaging was used in 70 patients with non-epithelial ovarian carcinoma and 23 patients with subserous nodes of uterine myoma.
  • The procedure can be used for differentiated diagnosis between non-epithelial ovarian carcinoma and subserous nodes of uterine myoma, as well as for appraisal of individual features of tumor so that adequate treatment might be selected.
  • [MeSH-major] Myoma / ultrasonography. Ovarian Neoplasms / ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18198619.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


76. Dao LN, Scheithauer BW, Erlandson RA, Young WF Jr, Aidan Carney J: Divergent myoid, neuroendocrine, and perineural differentiation in a nasal tumor of a patient with Carney complex. Am J Surg Pathol; 2008 Jan;32(1):167-71
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Divergent myoid, neuroendocrine, and perineural differentiation in a nasal tumor of a patient with Carney complex.
  • Computed tomography showed bilateral thalamic infarctions and also an unsuspected multicompartmental cystic neoplasm that had eroded the anterior clivus and extended forward into the nasopharynx.
  • Histologically, the mass appeared benign and was composed of spindle cells and multiple foci of striated muscle.
  • Immunohistochemically, the spindle cells were strongly reactive for S-100 protein and to a lesser extent for CD57, collagen IV, neuron-specific enolase, smooth muscle actin, epithelial membrane antigen, and glut-1.
  • The striated muscle cells were positive for desmin and myogenin.
  • Ultrastructurally, the spindle cells showed divergent differentiation along several cell lines, including smooth muscle, neuroendocrine, hybrid smooth muscle-neuroendocrine, perineural-like cells, and striated muscle.
  • [MeSH-major] Neoplasms, Muscle Tissue / ultrastructure. Neoplastic Syndromes, Hereditary / pathology. Nose Neoplasms / ultrastructure. Perineum / pathology

  • Genetic Alliance. consumer health - Carney Complex.
  • Genetic Alliance. consumer health - Pancreatic islet cell tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18162785.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Cobellis L, Pecori E, Rigatti F, Scaffa C, Rotondi M, Messalli EM: A rare case of female pelvic mass: angioleiomyoma of the broad ligament. Eur J Gynaecol Oncol; 2007;28(5):418-20

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Angioleiomyoma is a benign mesenchymal neoplasm composed of smooth muscle cells and thick-walled vessels.
  • Angioleiomyoma is a very rare tumor among the ever-expanding repertoire of growth variants described in benign uterine leiomyoma.
  • More rare is a solitary tumor of the broad ligament.
  • Thus angioleiomyoma of the broad ligament is an extremely rare benign tumor of the female pelvis.
  • The site of the benign mass was the left broad ligament of the uterus.
  • On pathologic examination of the specimen, the tumor was diagnosed as angioleiomyoma.
  • We present a case of angioleiomyoma of the broad ligament because of its extreme rarity and the large size of the tumor.
  • [MeSH-major] Adnexal Diseases / pathology. Angiomyoma / pathology. Broad Ligament

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17966227.001).
  • [ISSN] 0392-2936
  • [Journal-full-title] European journal of gynaecological oncology
  • [ISO-abbreviation] Eur. J. Gynaecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


78. Hurst BS, Elliot M, Matthews ML, Marshburn PB: Ultrasound-directed transvaginal myolysis: preclinical studies. J Minim Invasive Gynecol; 2007 Jul-Aug;14(4):502-5
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The ultimate goal is to develop a safe vaginal ultrasound-directed myolysis needle to treat uterine myomas.
  • The specific preclinical study objective was to determine the optimal power to coagulate myomas in hysterectomy specimens with a prototype needle in a prospective preclinical study with an echogenic insulated needle electrode.
  • Ultrasound-directed transvaginal myolysis may provide another option for women with uterine myomas if it is proven safe and effective in future clinical studies.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17630171.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


79. Maia H Jr, Pimentel K, Casoy J, Correia T, Freitas LA, Zausner B, Athayde C, Coutinho E: Aromatase expression in the eutopic endometrium of myomatous uteri: the influence of the menstrual cycle and oral contraceptive use. Gynecol Endocrinol; 2007 Jun;23(6):320-4
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: To detect aromatase expression in the endometrium of myomatous uteri and to correlate it with the location of the myoma, phase of the menstrual cycle, the presence of menorrhagia and oral contraceptive use.
  • Sixty-one patients had menorrhagia associated with intramural/submucous myomas and nine had subserous myomas and no excessive bleeding.
  • RESULTS: Aromatase p450 expression was detected more frequently in the eutopic endometrium of patients with submucous or intramural myomas than in those in the subserous group, and was significantly greater during the proliferative phase than during the luteal phase or following the use of oral contraceptives.
  • CONCLUSIONS: Aromatase expression in the endometrium was affected by the location of the myoma, the presence of symptoms, and the phase of the menstrual cycle.
  • Oral contraceptives, on the other hand, inhibited aromatase expression in the eutopic endometrium of patients with submucous/intramural myomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17616855.001).
  • [ISSN] 0951-3590
  • [Journal-full-title] Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • [ISO-abbreviation] Gynecol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contraceptives, Oral; EC 1.14.14.1 / Aromatase
  •  go-up   go-down


80. Al-Mahrizi S, Tulandi T: Treatment of uterine fibroids for abnormal uterine bleeding: myomectomy and uterine artery embolization. Best Pract Res Clin Obstet Gynaecol; 2007 Dec;21(6):995-1005
MedlinePlus Health Information. consumer health - Vaginal Bleeding.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Uterine myoma is a common benign tumour in women and most cases do not require treatment.
  • Excessive uterine bleeding is usually due to a submucous myoma or an intramural myoma that is encroaching into the uterine cavity.
  • Hysteroscopic myomectomy is highly effective in controlling menorrhagia that is related to submucous myoma.
  • For those with an intramural myoma, abdominal myomectomy results in good bleeding control.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17478123.001).
  • [ISSN] 1521-6934
  • [Journal-full-title] Best practice & research. Clinical obstetrics & gynaecology
  • [ISO-abbreviation] Best Pract Res Clin Obstet Gynaecol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 36
  •  go-up   go-down


81. Lemos MM, Karlen J, Tani E: Fine-needle aspiration cytology of angiomatoid malignant fibrous histiocytoma. Diagn Cytopathol; 2005 Aug;33(2):116-21
Genetic Alliance. consumer health - Histiocytoma, angiomatoid fibrous.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Angiomatoid malignant fibrous histiocytoma (AMFH) is a rare, low-grade malignant mesenchymal neoplasm that affects mostly the extremities of children and young adults.
  • The tumor cells showed mild to moderate anisocariosis, often with nucleolus and vast, fragile cytoplasm.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Muscle Neoplasms / pathology

  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 16007669.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Prapas Y, Kalogiannidis I, Prapas N: Laparoscopy vs laparoscopically assisted myomectomy in the management of uterine myomas: a prospective study. Am J Obstet Gynecol; 2009 Feb;200(2):144.e1-6
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopy vs laparoscopically assisted myomectomy in the management of uterine myomas: a prospective study.
  • Laparoscopic (n = 40) vs laparoscopically assisted myomectomy (n = 76) were compared for the management of no more than 3 intramural or subserous uterine myomas, of a maximum diameter of 90 mm.
  • RESULTS: The patients' characteristics by age, parity, body mass index, number and location of myomas were well balanced between the 2 study groups.
  • The mean diameter of the myomas was the only characteristic significantly higher in the laparoscopically assisted myomectomy group.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19019334.001).
  • [ISSN] 1097-6868
  • [Journal-full-title] American journal of obstetrics and gynecology
  • [ISO-abbreviation] Am. J. Obstet. Gynecol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Vilos GA, Vilos AG, Abu-Rafea B, Pron G, Kozak R, Garvin G: Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas. Fertil Steril; 2006 May;85(5):1478-83
Hazardous Substances Data Bank. GOSERELIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas.
  • OBJECTIVE: To determine if goserelin immediately after uterine artery embolization (UAE) affected myoma reduction.
  • Uterine and myoma volumes were measured by ultrasound 2 weeks before UAE and at 3, 6, and 12 months.
  • CONCLUSION(S): The addition of goserelin therapy to UAE did not alter the reduction rate or volume of uterine myomas.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16579996.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal; 0F65R8P09N / Goserelin
  •  go-up   go-down


84. Mason TC, Adair J, Lee YC: Postpartum pyomyoma. J Natl Med Assoc; 2005 Jun;97(6):826-8
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leiomyomata are common benign tumors of the uterus and female pelvis.
  • Myomas have been reported in 25% of Caucasian American women and 50% of African-American women.
  • Considering the high incidence of uterine myomata in women of reproductive age, they are reported as complications in only 2% of pregnancies.
  • Pyomyoma (suppurative leiomyoma) a rare complication results from infarction and infection of a leiomyoma.
  • This report documents a pyomyoma that presented as a postpartum enlargement of a previously known leiomyoma.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] South Med J. 2001 May;94(5):508-11 [11372803.001]
  • [Cites] Obstet Gynecol. 1986 Jul;68(1):46-8 [3523329.001]
  • [Cites] J Reprod Med. 1996 May;41(5):375-8 [8725768.001]
  • [Cites] Obstet Gynecol Surv. 1990 Sep;45(9):563-9 [2204849.001]
  • [Cites] J Ark Med Soc. 1986 Aug;83(3):138-47 [2944873.001]
  • (PMID = 16035584.001).
  • [ISSN] 1943-4693
  • [Journal-full-title] Journal of the National Medical Association
  • [ISO-abbreviation] J Natl Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 9
  • [Other-IDs] NLM/ PMC2569512
  •  go-up   go-down


85. Yamada N, Uchida R, Fuchida S, Okano A, Okamoto M, Ochiai N, Iwasa H, Shimazaki C: CD5+ Epstein-Barr virus-positive intravascular large B-cell lymphoma in the uterus co-existing with huge myoma. Am J Hematol; 2005 Mar;78(3):221-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD5+ Epstein-Barr virus-positive intravascular large B-cell lymphoma in the uterus co-existing with huge myoma.
  • A 42-year-old female underwent hysterectomy because of a huge uterine mass.
  • Histologically, she was diagnosed as having intravascular lymphoma co-existing with myoma uteri.
  • She received the combination chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisolone) together with rituximab and has been well without definite disease progression.
  • So far, this is the first case of CD5+ EBV+ intravascular large B-cell lymphoma (CD5+ EBV+ IVLBL) in the uterus of a patient who was incidentally diagnosed and successfully treated.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15726593.001).
  • [ISSN] 0361-8609
  • [Journal-full-title] American journal of hematology
  • [ISO-abbreviation] Am. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD5
  •  go-up   go-down


86. Zarineh A, Kozovska ME, Brown WG, Elder DE, Rabkin MS: Smooth muscle hamartoma associated with a congenital pattern melanocytic nevus, a case report and review of the literature. J Cutan Pathol; 2008 Oct;35 Suppl 1:83-6
Genetic Alliance. consumer health - Nevus.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Smooth muscle hamartoma associated with a congenital pattern melanocytic nevus, a case report and review of the literature.
  • Smooth muscle hamartoma (SMH) is a rare benign congenital or acquired lesion sometimes associated with Becker's nevus (Becker's melanosis).
  • The patient is a 49-year-old male with a history of a changing 'mole' on the left upper back.
  • The base of the lesion consisted of intersecting smooth muscle fascicles focally admixed with spindled melanocytes.
  • The smooth muscle component was strongly positive for smooth muscle actin and h-caldesmon.
  • [MeSH-major] Hamartoma / complications. Hamartoma / pathology. Muscle, Smooth / pathology. Nevus, Pigmented / complications. Nevus, Pigmented / congenital
  • [MeSH-minor] Actins / metabolism. Antigens, Neoplasm / metabolism. Calmodulin-Binding Proteins / metabolism. Humans. Immunohistochemistry. MART-1 Antigen. Male. Melanoma-Specific Antigens. Middle Aged. Neoplasm Proteins / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright Blackwell Munksgaard 2008.
  • (PMID = 18544054.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, Neoplasm; 0 / Calmodulin-Binding Proteins; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins
  •  go-up   go-down


87. Damiani A, Melgrati L, Marziali M, Sesti F, Piccione E: Laparoscopic myomectomy for very large myomas using an isobaric (gasless) technique. JSLS; 2005 Oct-Dec;9(4):434-8
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic myomectomy for very large myomas using an isobaric (gasless) technique.
  • OBJECTIVES: Laparoscopic myomectomy using pneumoperitoneum for large myomas (> or = 8 cm) is hindered by several factors, such as the increased operative time, the risk of perioperative bleeding, and the risk of conversion to laparotomy.
  • The aim of this study was to evaluate the feasibility, reproducibility, and safety of isobaric laparoscopic myomectomy for very large myomas > or = 10 cm using a subcutaneous abdominal wall-lifting device.
  • METHODS: A series of 24 consecutive patients with at least 1 symptomatic myoma > or = 10 cm underwent a gasless laparoscopic myomectomy with the Laparotenser device.
  • The size of the dominant myoma varied from 10 cm to 20 cm.
  • CONCLUSION: Gasless laparoscopic myomectomy is feasible, reproducible, and safe for removing very large myomas.
  • Therefore, it can represent an excellent option for the minimally invasive removal of very large myomas.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Reprod. 2000 Apr;15(4):869-73 [10739835.001]
  • [Cites] Surg Endosc. 1999 Sep;13(9):890-3 [10449846.001]
  • [Cites] J Am Assoc Gynecol Laparosc. 2001 May;8(2):231-40 [11342730.001]
  • [Cites] Gynecol Endocrinol. 2001 Apr;15(2):129-34 [11379009.001]
  • [Cites] Eur J Gynaecol Oncol. 2003;24(1):79-82 [12691325.001]
  • [Cites] JSLS. 2003 Apr-Jun;7(2):89-95 [12856836.001]
  • [Cites] J Reprod Med. 2003 Oct;48(10):792-8 [14619647.001]
  • [Cites] J Am Assoc Gynecol Laparosc. 2003 Nov;10(4):461-8 [14738629.001]
  • [Cites] Surg Endosc. 1993 Jan-Feb;7(1):57-9 [8424237.001]
  • [Cites] Arch Surg. 1993 Oct;128(10):1102-7 [8215870.001]
  • [Cites] Surg Today. 1993;23(9):786-90 [8219611.001]
  • [Cites] Surg Laparosc Endosc. 1991 Jun;1(2):98-100 [1669391.001]
  • [Cites] J Laparoendosc Surg. 1993 Dec;3(6):587-91 [8111114.001]
  • [Cites] Int J Fertil Menopausal Stud. 1994 Jan-Feb;39(1):39-44 [8167679.001]
  • [Cites] Int Surg. 1994 Oct-Dec;79(4):314-6 [7713698.001]
  • [Cites] Am J Obstet Gynecol. 1996 Feb;174(2):654-8 [8623802.001]
  • [Cites] Obstet Gynecol Clin North Am. 1995 Dec;22(4):757-80 [8786880.001]
  • [Cites] Hum Reprod. 1996 Jul;11(7):1427-32 [8671480.001]
  • [Cites] Contracept Fertil Sex. 1996 Oct;24(10):751-6 [8974613.001]
  • [Cites] J Am Assoc Gynecol Laparosc. 1996 May;3(3):375-81 [9050659.001]
  • [Cites] Surg Endosc. 1997 Oct;11(10):1006-9 [9381337.001]
  • [Cites] Hum Reprod. 1997 Sep;12(9):1927-30 [9363708.001]
  • [Cites] Hum Reprod. 1998 Aug;13(8):2102-6 [9756277.001]
  • [Cites] Fertil Steril. 1999 Mar;71(3):571-4 [10065802.001]
  • [Cites] Hum Reprod Update. 2000 Nov-Dec;6(6):588-94 [11129692.001]
  • (PMID = 16381362.001).
  • [ISSN] 1086-8089
  • [Journal-full-title] JSLS : Journal of the Society of Laparoendoscopic Surgeons
  • [ISO-abbreviation] JSLS
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3015631
  •  go-up   go-down


88. Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F: Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol; 2010 Jan-Feb;17(1):59-65
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hysteroscopic management of large symptomatic submucous uterine myomas.
  • STUDY OBJECTIVE: To evaluate the feasibility of hysteroscopic resection of large submucous uterine myomas.
  • DESIGN: Prospective study (Canadian Task Force classification II-3).
  • PATIENTS: Thirty-three women with submucous myomas 5 cm or larger in diameter with menorrhagia, dysmenorrhea, or infertility.
  • Possibility of 1-step resection; complication rate, and disease recurrence were also considered.
  • According to the Wamsteker classification, 84.8% were type II myomas, whereas 93.9% scored 5 or higher according to the classification of Lasmar and colleagues.
  • Patients with myomas larger than 5 cm or with a Lasmar score higher than 7 were more likely to undergo a 2-step procedure.
  • In patients with myomas larger than 6 cm, recovery time was significantly longer than in those with smaller myomas.
  • CONCLUSIONS: Hysteroscopic myomectomy can be the treatment of choice in symptomatic patients with a submucous myoma with diameter of 6 cm or less.
  • However, for myomas 6 cm or larger in diameter, this approach is less attractive.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 AAGL. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20129334.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Murtoniemi K, Pirinen E, Kähkönen M, Heiskanen N, Heinonen S: Smooth muscle tumor of the placenta - an entrapped maternal leiomyoma: a case report. J Med Case Rep; 2009;3:7302

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Smooth muscle tumor of the placenta - an entrapped maternal leiomyoma: a case report.
  • Tumors arising from the placental tissue include two distinct histological types: the benign vascular tumor, chorangioma, and very rarely, choriocarcinoma.
  • Benign leiomyomas, in contrast, are very common tumors of the uterine wall and occur in 0.1% to 12.5% of all pregnant women.
  • This case is possibly the first report on this kind of a placental tumor which has been examined using both immunohistochemistry and chromosome analysis.
  • CASE PRESENTATION: A 34-year-old G4P3 Caucasian woman was followed up antenatally because of a stillbirth in her previous pregnancy.
  • Histologically, the tumor was a benign leiomyoma and this finding was supported by immunohistochemistry.
  • Chromosomes of the neoplasm were studied by the fluorescence in situ hybridization technique and the tumor was found to carry XX chromosomes.
  • CONCLUSION: A rare benign smooth muscle neoplasm involving the placental parenchyma is presented.
  • The tumor was a uterine leiomyoma of maternal origin, which had become entrapped by the placenta.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Indian J Pathol Microbiol. 2005 Apr;48(2):223-4 [16758675.001]
  • [Cites] Obstet Gynecol Surv. 2005 Feb;60(2):132-8 [15671902.001]
  • [Cites] Am J Surg Pathol. 1998 Mar;22(3):355-9 [9500778.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1991;419(4):309-15 [1949613.001]
  • [Cites] Virchows Arch. 2000 Feb;436(2):167-71 [10755608.001]
  • [Cites] South Med J. 1985 Jul;78(7):863-4 [4012385.001]
  • [Cites] J Reprod Med. 2001 Oct;46(10):937-40 [11725743.001]
  • [Cites] Int J Gynecol Pathol. 2001 Jul;20(3):284-8 [11444205.001]
  • [Cites] Histopathology. 2000 Sep;37(3):287-9 [10971709.001]
  • [Cites] Gynecol Oncol. 1989 Apr;33(1):108-11 [2649418.001]
  • (PMID = 19830174.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2726536
  •  go-up   go-down


90. van Riemsdijk VM, Graziosi GC, Veersema S, Bongers MY: Vaginal myoma expulsion after NovaSure endometrial ablation. J Minim Invasive Gynecol; 2009 Jul-Aug;16(4):496-7
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal myoma expulsion after NovaSure endometrial ablation.
  • There was a small submucosal type 2 myoma of 2 cm in her normal sized uterus.
  • A myoma of 4 cm was being expelled from the uterus.

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19573829.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Redecha M Jr, Holomán K, Javorka V, Mizícková M, Ferianec V, Papcun P, Krizko M Jr, Redecha M Sr: Myoma expulsion after uterine artery embolization. Arch Gynecol Obstet; 2009 Dec;280(6):1023-4
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myoma expulsion after uterine artery embolization.
  • Uterine artery embolization (UAE) has become a standard therapy in the treatment of symptomatic uterine myomas.
  • One of them is myoma expulsion.
  • A 32-year-old woman was sent to our hospital with diagnosed intramural myoma with dysmenorrhea and pressure symptoms.
  • We diagnosed expulsion of necrotic myoma and performed transvaginal resection.
  • Expulsion of intramural myoma can be thus considered as definite treatment and not a complication of embolization therapy.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19319549.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


92. Fernandez H, Farrugia M, Jones SE, Mauskopf JA, Oppelt P, Subramanian D: Rate, type, and cost of invasive interventions for uterine myomas in Germany, France, and England. J Minim Invasive Gynecol; 2009 Jan-Feb;16(1):40-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rate, type, and cost of invasive interventions for uterine myomas in Germany, France, and England.
  • STUDY OBJECTIVE: The objective of our study was to quantify the rate, type, and cost of interventions for uterine myomas to payers in Germany, France, and England.
  • DESIGN CLASSIFICATION: II-3.
  • PATIENTS: Women admitted for a surgical or radiologic intervention for uterine myomas.
  • INTERVENTIONS: Surgical or radiologic interventions for uterine myomas.
  • MEASUREMENTS AND MAIN RESULTS: We identified the number and type of hospital admissions involving surgical or radiologic interventions for uterine myomas, through the analysis of national hospital activity databases from each country.
  • In 2005, the number (rate) of hospital admissions involving interventions for uterine myomas was 64 299 (1.53/1000 women) in Germany, 37 787 (1.17/1000 women) in France, and 18 274 (0.71/1000 women) in England.
  • The percentage of interventions for uterine myomas that included a hysterectomy was 84.9% in Germany, 59.7% in France, and 64.1% in England.
  • CONCLUSION: The number of admissions and costs associated with interventions for uterine myomas are substantial in the 3 European countries studied.
  • Hysterectomy is the most frequent surgical intervention used to treat uterine myomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18996060.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


93. Discepola F, Valenti DA, Reinhold C, Tulandi T: Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol; 2007 Dec;110(6):1301-3
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy.
  • Accordingly, we evaluated the location and course of arterial blood vessels surrounding the myoma.
  • RESULTS: We encountered 592 arterial blood vessels surrounding the myoma.
  • The vessels could be seen encircling the surface of the myoma.
  • The dominant myoma was located on anterior (n=30), posterior (n=17), and fundal part of the uterus (n=13).
  • There was no difference in the diameter (6.9+/-2.7 cm, 5.8+/-0.7 cm, and 6.7+/-0.5 cm) and volume of the myoma (268.6+/-52.7 cm(3), 197.0+/-64.5 cm(3), and 199.3+/-40.5 cm(3)) among anterior, posterior, and fundal, respectively.
  • There were significantly more blood vessels in the 30-60 degree group among anterior myoma (n=88, 42.5%) than in 0-30 degree (n=59, 28.5%, P=.004, 95% confidence interval [CI] 0.36-0.81) and 60-90 degree groups (n=60, 29.0%, 95% CI 1.2-2.7).
  • Similar findings were found among posterior myoma (0-30 degrees n=26, 21.7%; 30-60 degrees n=59, 49.2%; P<.001, 95% CI 0.16-0.50; 60-90 degrees 35 (29.2%), P<.002, 95% CI 1.37-3.9).
  • Among fundal myomas, there was no difference in the number of vessels in the 0-30 degree (n=28, 28.6%), 60-90 degree (n=40, 40.8%), and in 60-90 degree groups (n=30, 30.6%).
  • CONCLUSION: Arterial blood vessels travel mostly diagonally on the surface of anterior and posterior myomas.
  • There was no predominant pattern in the course of the arteries on fundal myomas.
  • These findings suggest that regardless of the direction of the myomectomy incision, arterial blood vessels on myoma surface could be injured.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18055724.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Kourda J, Ismail O, Smati BH, Ayadi A, Kilani T, El Mezni F: Benign myoepithelioma of the lung - a case report and review of the literature. Cases J; 2010;3(1):25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign myoepithelioma of the lung - a case report and review of the literature.
  • INTRODUCTION: Benign myoepithelioma is extremely rare in the lung, to the best of our knowledge; only five cases have been reported in the literature.
  • Histologically, there was a proliferation of small cells of a plasmocytoid-type, with a predominantly whorled pattern.
  • No mitotic activity or necrosis was seen in the tumor.
  • Immuhistochemically, the tumor cells positive for smooth muscle actin, vimentine, and S100 protein.
  • The diagnosis of benign myoepithelioma of the lung is so confirmed.
  • CONCLUSION: Benign myoepithelioma is a rare pulmonary neoplasm distinct from pleomorphic adenoma, which should be considered in the differential diagnosis of lung nodules.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 2005 Nov;237(2):395-400 [16244247.001]
  • [Cites] Rev Pneumol Clin. 2004 Nov;60(5 Pt 1):282-4 [15687912.001]
  • [Cites] Lung Cancer. 1998 Apr;20(1):47-56 [9699187.001]
  • [Cites] Oncology. 1998 Sep-Oct;55(5):431-4 [9732221.001]
  • [Cites] Ultrastruct Pathol. 1995 Sep-Oct;19(5):335-45 [7483010.001]
  • [Cites] Histopathology. 1990 Oct;17(4):311-7 [2175294.001]
  • [Cites] Arch Pathol Lab Med. 1987 Nov;111(11):1082-5 [2821955.001]
  • [Cites] Am J Surg Pathol. 1984 Nov;8(11):803-20 [6209992.001]
  • [Cites] J Histochem Cytochem. 2003 Feb;51(2):133-9 [12533521.001]
  • [Cites] Chest. 2003 Jan;123(1 Suppl):89S-96S [12527568.001]
  • [Cites] Arch Pathol Lab Med. 2001 Nov;125(11):1494-6 [11698012.001]
  • [Cites] Eur J Cardiothorac Surg. 2000 Feb;17(2):187-9 [10731657.001]
  • (PMID = 20180958.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2828429
  •  go-up   go-down


95. Koch P, Petri M, Paradowska A, Stenzinger A, Sturm K, Steger K, Wimmer M: PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma. Prostate; 2009 Dec 1;69(16):1751-62
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma.
  • In this study the expression of PTPIP51 and its in vitro interaction partners was investigated in human benign prostate hyperplasia (BPH) and in prostate carcinoma (PCa).
  • RESULTS: PTPIP51 mRNA and protein expression was detected in prostatic epithelia of BPH and in tumor cells of PCa, respectively, and within smooth muscle cells of the stromal compartment.
  • A stronger expression was present in nerve fibers, particularly in PCa, in immune cells and in smooth muscle and endothelial cells of vessels of BPH and PCa.
  • [MeSH-minor] Aged. CpG Islands / genetics. Endothelial Cells / metabolism. Epithelium / metabolism. Humans. Immune System / metabolism. Immune System / pathology. Male. Microarray Analysis. Middle Aged. Muscle, Smooth, Vascular / metabolism. Muscle, Smooth, Vascular / pathology. Myocytes, Smooth Muscle / metabolism. Neoplasm Invasiveness. Nerve Fibers / metabolism. Prostate / blood supply. Prostate / innervation. Prostate / metabolism. Tissue Distribution

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Wiley-Liss, Inc.
  • (PMID = 19691131.001).
  • [ISSN] 1097-0045
  • [Journal-full-title] The Prostate
  • [ISO-abbreviation] Prostate
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mitochondrial Proteins; 0 / RNA, Messenger; EC 3.1.3.48 / FAM82A2 protein, human; EC 3.1.3.48 / Protein Tyrosine Phosphatases
  •  go-up   go-down


96. Gleason BC, Fletcher CD: Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential. Am J Surg Pathol; 2008 Mar;32(3):354-62
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
  • Benign fibrous histiocytoma (FH) is one of the most common mesenchymal neoplasms of the skin.
  • Deep benign FH is an uncommon and poorly recognized clinical subtype that arises in subcutaneous or deep soft tissue.
  • Immunohistochemistry revealed expression of CD34 in 20/50 cases (40%), smooth muscle actin in 15/40 (38%), and focal desmin in 1/12 (8%).
  • Of the 37 patients for whom clinical follow-up was available (median, 40 mo), 8 (22%) had a local recurrence; in all 8 cases, the tumor had been marginally or incompletely excised.
  • Metastases occurred in 2 patients (5%), both of whom ultimately died of disease; however, this number is likely exaggerated due to consultation bias.
  • The metastasizing tumors were large (6 and 9 cm) and 1 had tumor necrosis but they were otherwise histologically identical to the nonmetastasizing lesions.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Neoplasm Metastasis / pathology. Skin Neoplasms / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Actins / analysis. Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD34 / analysis. Child. Desmin / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Mitosis. Necrosis. Neoplasm Recurrence, Local

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18300816.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD34; 0 / Desmin
  •  go-up   go-down


97. Dalainas I: Vascular smooth muscle tumors: review of the literature. Int J Surg; 2008 Apr;6(2):157-63

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vascular smooth muscle tumors: review of the literature.
  • Vascular smooth muscle tumors are very rare.
  • They can be benign or malign.
  • Intravascular leiomyomatosis is a benign neoplasm that extends through the veins and caries significant morbidity.
  • Angioleiomyoma is a benign neoplasm of the extremities that caries minimal morbidity.
  • This study reviews literature for epidemiology, clinical presentation, diagnosis and management of patients with vascular smooth muscle tumors.
  • [MeSH-major] Neoplasms, Muscle Tissue / diagnosis. Neoplasms, Muscle Tissue / therapy. Vascular Neoplasms / diagnosis. Vascular Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17531562.001).
  • [ISSN] 1743-9159
  • [Journal-full-title] International journal of surgery (London, England)
  • [ISO-abbreviation] Int J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 70
  •  go-up   go-down


98. Lazarov N, Lazarov L, Lazarov S: [Rare form of cervix carcinoma, infiltrating cervical myoma]. Akush Ginekol (Sofiia); 2010;49(3):48-9
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rare form of cervix carcinoma, infiltrating cervical myoma].
  • The authors describe rare case of carcinoma colli uteri, which grows to infiltrate submucose cervical myoma.
  • [MeSH-major] Myoma / pathology. Uterine Cervical Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20734657.001).
  • [ISSN] 0324-0959
  • [Journal-full-title] Akusherstvo i ginekologii︠a︡
  • [ISO-abbreviation] Akush Ginekol (Sofiia)
  • [Language] bul
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


99. Cheng MH, Chao HT, Wang PH: Medical treatment for uterine myomas. Taiwan J Obstet Gynecol; 2008 Mar;47(1):18-23
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Medical treatment for uterine myomas.
  • Uterine myomas are the most common benign tumors in the female reproductive tract.
  • Most women with myomas are asymptomatic.
  • Therefore, expectant observation and follow-up are often recommended for these myoma patients.
  • However, myomas may cause menstrual symptoms, pelvic pain, pressure complaints, subfertility or pregnancy-related complications, with resultant requests for a definitive treatment.
  • The management of myomas has become multidisciplinary in the past 20 years.
  • Medical therapy is an option for women with symptomatic myomas who prefer non-surgical treatment, consider fertility preservation, or expect a less aggressive operation after shrinkage of the uterine volume.
  • This review will summarize the recent well-documented drugs for the management of uterine myomas.

  • MedlinePlus Health Information. consumer health - Hormones.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • Hazardous Substances Data Bank. PROGESTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18400578.001).
  • [ISSN] 1875-6263
  • [Journal-full-title] Taiwanese journal of obstetrics & gynecology
  • [ISO-abbreviation] Taiwan J Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Hormones; 33515-09-2 / Gonadotropin-Releasing Hormone; 4G7DS2Q64Y / Progesterone
  • [Number-of-references] 68
  •  go-up   go-down


100. Loffer FD: Endometrial ablation in patients with myomas. Curr Opin Obstet Gynecol; 2006 Aug;18(4):391-3
MedlinePlus Health Information. consumer health - Uterine Fibroids.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrial ablation in patients with myomas.
  • PURPOSE OF REVIEW: This review evaluates how the presence of uterine myomas may limit the ability to provide endometrial ablations for patients with menorrhagia, affect subsequent postoperative course and alter long-term outcome.
  • RECENT FINDINGS: New instrumentation and the off-label use of some global ablation techniques allow some selected patients with submucosal myomas to be treated solely by endometrial ablation.
  • The addition of an endometrial ablation in patients undergoing a hysteroscopic myomectomy improves bleeding and their long-term control, but does not decrease the subsequent need for a hysterectomy.
  • Necrosis of intramural myomas is a rare postoperative complication.
  • Untreated myomas may continue to increase in size and lead to a hysterectomy.
  • SUMMARY: The presence of myomas in patients undergoing endometrial ablation may compromise the results and lead to later problems, but most patients can be treated successfully and myomas are not an absolute contraindication.

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16794418.001).
  • [ISSN] 1040-872X
  • [Journal-full-title] Current opinion in obstetrics & gynecology
  • [ISO-abbreviation] Curr. Opin. Obstet. Gynecol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 24
  •  go-up   go-down






Advertisement